Document:

EX-10.9

 Exhibit 10.9 

2013 EQUITY INCENTIVE PLAN 
 WITH

 CALIFORNIA SUPPLEMENT 

ADOPTED BY THE BOARD ON 12 NOVEMBER 2013 

APPROVED BY SHAREHOLDERS ON 12 NOVEMBER 2013 

AMENDED BY THE BOARD ON 7 MAY 2014 

APPROVED BY SHAREHOLDERS ON 7 MAY 2014 

AMENDED BY THE BOARD ON 5 MARCH 2018 

APPROVED BY SHAREHOLDERS ON 22 MARCH 2018 

AMENDED BY THE BOARD ON 31 MAY 2018 

AMENDED BY THE BOARD ON 9 NOVEMBER 2018 

APPROVED BY SHAREHOLDERS ON 28 NOVEMBER 2018 

AMENDED BY THE BOARD ON 18 NOVEMBER 2020 

APPROVED BY SHAREHOLDERS ON 4 DECEMBER 2020 

ROCKLEY PHOTONICS LIMITED 

 Rockley Photonics Limited 

2013 EQUITY INCENTIVE PLAN 

	1.	 PURPOSE 

The purpose of this 2013 Equity Incentive Plan (the “Plan”) of Rockley Photonics Limited, a company registered in
England and Wales under No. 08683015 (the “Company”), is to advance the interests of the Company’s shareholders by enhancing the Company’s ability to attract, retain and motivate persons who are expected to
make important contributions to the Company and by providing such persons with equity ownership opportunities and performance- based incentives that are intended to better align the interests of such persons with those of the Company’s
shareholders. Except where the context otherwise requires, the term “Company” shall include any of the Company’s present or future parent or subsidiary corporations as defined in Sections 424(e) or (f) of the
Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”) and any other business venture (including, without limitation, joint venture or limited liability company) in which the
Company has a controlling interest, as determined by the Board of Directors of the Company (the “Board”). 
  

	2.	 ELIGIBILITY 

All of the Company’s employees, officers, directors, consultants and advisors are eligible to be granted options, restricted stock,
restricted stock units (“RSUs”) and other stock-based awards (each, an “Award”) under the Plan. Each person who receives an Award under the Plan is deemed a “Participant”. 

 

	3.	 ADMINISTRATION AND DELEGATION 

 

	3.1	 Administration by Board of Directors. The Plan will be administered by the Board. The Board shall
have authority to grant Awards and to adopt, amend and repeal such administrative rules, guidelines and practices relating to the Plan as it shall deem advisable. The Board may construe and interpret the terms of the Plan and any Award agreements
entered into under the Plan. The Board may correct any defect, supply any omission or reconcile any inconsistency in the Plan or any Award in the manner and to the extent it shall deem expedient to carry the Plan into it shall be the sole and final
judge of such expediency. All decisions by the Board shall be made in the Board’s sole discretion and shall be final and binding on all persons having or claiming any interest in the Plan or in any Award. No director or person acting pursuant
to the authority delegated by the Board shall be liable for any action or determination relating to or under the Plan made in good faith. 

  
 1 

	3.2	 Appointment of Committees. To the extent permitted by applicable law, the Board may delegate any
or all of its powers under the Plan to one or more committees or subcommittees of the Board (a “Committee”). All references in the Plan to the “Board” shall mean the Board or a Committee of the Board
to the extent that the Board’s powers or authority under the Plan have been delegated to such Committee. 

  

	4.	 SHARES AVAILABLE FOR AWARDS 

Subject to adjustment under Section 6, Awards may be made under the Plan for up to 11,458,989 ordinary shares of £0.00001 pence each
in the capital of the Company (“Shares”) any or all of which may be used for Incentive Stock Options (as defined at 5.2(a) below). 

If any Award expires or is terminated, surrendered or cancelled without having been fully exercised or is forfeited in whole or in part
(including as the result of shares in the capital of the Company being repurchased by the Company at the original issuance price pursuant to a contractual repurchase right) or results in any such shares not being issued, the unused shares covered by
such an Award shall again be available for the grant of Awards under the Plan. Further, shares in the capital of the Company tendered to the Company by a Participant to exercise an Award shall be added to the number of shares available for the grant
of Awards under the Plan. However, in the case of Incentive Stock Options (as hereinafter defined), the foregoing provisions shall be subject to any limitations under the Code. 

 

	4.1	 Substitute Awards. In connection with a merger or consolidation of an entity with the Company or
the acquisition by the Company of property or stock of an entity, the Board may grant Awards in substitution for any options or other stock or stock-based awards granted by such entity or an affiliate thereof. Substitute Awards may be granted on
such terms as the Board deems appropriate in the circumstances, notwithstanding any limitations on Awards contained in the Plan. Substitute Awards shall not count against the overall share limit set forth in Section 4.1, except as may be
required by reason of Section 422 and related provisions of the Code. 

  

	4.2	 Deed Poll. The Board may grant Awards by entering into a deed poll in a form approved by the
Board and, as soon as practicable after the Company has executed the deed poll, the Board shall enter into an Award agreement in a form approved by the Board. 

  
 2 

	5.	 STOCK OPTIONS 

 

	5.1	 General. The Board may grant options to purchase shares in the capital of the Company (each, an
“Option”) and determine the number of shares in the capital of the Company to be covered by each Option, the exercise price of each Option and the conditions and limitations applicable to the exercise of each Option,
including conditions relating to applicable US federal or state securities laws, as it considers necessary or advisable. An Option that is not intended to be an Incentive Stock Option (as hereinafter defined) or an EMI Option (as hereinafter
defined) shall be designated a “Nonstatutory Stock Option”. 

  

	5.2	 (a) Incentive Stock Options. An Option that the Board intends to be an “incentive stock
option” as defined in Section 422 of the Code (an “Incentive Stock Option”) shall only be granted to employees of Rockley Photonics Limited, any of Rockley Photonics Limited’s present or future parent or
subsidiary corporations as defined in Sections 424(e) or (f) of the Code, and any other entities the employees of which are eligible to receive Incentive Stock Options under the Code, and shall be subject to and shall be construed consistently
with the requirements of Section 422 of the Code. The Company shall have no liability to a Participant, or any other party, if an Option (or any part thereof) that is intended to be an Incentive Stock Option is not an Incentive Stock Option or
for any action taken by the Board, including without limitation the conversion of an Incentive Stock Option to a Nonstatutory Stock Option. 

  

	 	(b)	 EMI Options. An Option that the Board intends to be an enterprise management incentive option
under the terms of Schedule 5 to the UK Income Tax (Earnings and Pensions) Act 2003 (“Schedule 5”) (an “EMI Option”) shall only be granted to an employee of Rockley Photonics Limited or its parent or
subsidiary corporations who satisfies the requirements of Schedule 5 and the Company shall have no liability to a Participant if an Option (or any part thereof) that is intended to be an EMI Option is not or ceases to be a qualifying option under
Schedule 5. 

  

	5.3	 Exercise Price. The Board shall establish the exercise price of each Option and specify the
exercise price in the applicable option agreement. For US residents the exercise price shall be not less than 100% of the Fair Market Value (as defined below) on the date the Option is granted. 

 

	5.4	 Duration of Options. Each Option shall be exercisable at such times and subject to such terms and
conditions as the Board may specify in the applicable option agreement. 

  

	5.5	 Exercise of Option—Notice of exercise. Options may be exercised by delivery to the Company
of a written notice of exercise signed by the proper person or by any other form of notice (including electronic notice) approved by the Board together with payment in full as specified in Section 5.6 for the number of shares for which the
Option is exercised. 

  

	5.6	 Payment upon Exercise. Shares in the capital of the Company purchased upon the exercise of an
Option granted under the Plan shall be paid for in cash or by check, payable to the order of the Company, or as otherwise specified in the applicable option agreement at the time of grant. 

  
 3 

	6.	 RESTRICTED STOCK; RESTRICTED STOCK UNITS 

 

	6.1	 General. The Board may grant Awards entitling recipients to acquire shares in the capital of the
Company (“Restricted Stock”), subject to the right of the Company to repurchase all or part of such shares at their issue price or other stated or formula price (or to require forfeiture of such shares if issued at no cost)
from the recipient in the event that conditions specified by the Board in the applicable Award are not satisfied prior to the end of the applicable restriction period or periods established by the Board for such Award. Instead of granting Awards for
Restricted Stock, the Board may grant Awards entitling the recipient to receive shares in the capital of the Company or cash to be delivered at the time such Award vests (“Restricted Stock Units”) (Restricted Stock and
Restricted Stock Units are each referred to herein as a “Restricted Stock Award”). 

  

	6.2	 Terms and Conditions for All Restricted Stock Awards. The Board shall determine the terms and
conditions of a Restricted Stock Award, including the conditions for vesting and repurchase (or forfeiture) and the issue price, if any. 

  

	6.3	 Additional Provisions Relating to Restricted Stock. 

(a) Dividends. Participants holding shares of Restricted Stock will be entitled to all ordinary cash dividends paid with respect
to such shares, unless otherwise provided by the Board. Unless otherwise provided by the Board, if any dividends or distributions are paid in shares, or consist of a dividend or distribution to holders of shares in the capital of the Company other
than an ordinary cash dividend, the shares, cash or other property will be subject to the same restrictions on transferability and forfeitability as the shares of Restricted Stock with respect to which they were paid. Each dividend payment will be
made no later than the end of the calendar year in which the dividends are paid to shareholders of that class of shares or, if later, the 15th day of the third month following the date the dividends are paid to shareholders of that class of shares.

  

	 	(b)	 Share Certificates. The Company may require that any share certificates issued in respect of
shares of Restricted Stock shall be held by the Company, together with a stock transfer form endorsed in blank, with the Company (or its designee). At the expiration of the applicable restriction periods, the Company (or such designee) shall deliver
the certificates no longer subject to such restrictions to the Participant or if the Participant has died, to the beneficiary designated, in a manner determined by the Board, by a Participant to receive amounts due or exercise rights of the
Participant in the event of the Participant’s death (the “Designated Beneficiary”). In the absence of an effective designation by a Participant, “Designated Beneficiary” shall mean the
Participant’s estate. 

  
 4 

	7.	 OTHER STOCK-BASED AWARDS 

Other Awards of shares in the capital of the Company, and other Awards that are valued in whole or in part by reference to, or are otherwise
based on, shares in the capital of the Company or other property, may be granted hereunder to Participants (“Other Stock-Based Awards”), including without limitation stock appreciation rights (“SARs”)
and Awards entitling recipients to receive shares in the capital of the Company to be delivered in the future. Such Other Stock- Based Awards shall also be available as a form of payment in the settlement of other Awards granted under the Plan or as
payment in lieu of compensation to which a Participant is otherwise entitled. Other Stock-Based Awards may be paid in shares in the capital of the Company or cash, as the Board shall determine. Subject to the provisions of the Plan, the Board shall
determine the terms and conditions of each Other Stock-Based Award, including any purchase price applicable thereto. 
  

	8.	 ADJUSTMENTS FOR CHANGES IN THE SHARE CAPITAL OF THE COMPANY AND CERTAIN OTHER EVENTS

  

	8.1	 Changes in Capitalization. 

 

	 	(a)	 Adjustment. The number of shares available for Award under the Plan, the number of shares over
which an Option is granted and the exercise price per share subject to Option, the number of shares subject to and the repurchase price per share subject to each outstanding Restricted Stock Award, and the terms of each other outstanding Award may
be adjusted in such manner as the Board shall determine following any capitalization issue (other than a scrip dividend), rights issue, recapitalization, subdivision, consolidation, reduction or other variation of share capital of the Company.

  

	 	(b)	 Limitation or adjustments. No adjustment under Section 8.1(a) above shall be made which would
reduce the exercise price per share subject to Option to subscribe for shares in the capital of the Company below the nominal value of a share unless and to the extent that the Board: 

 

	 	(i)	 is authorized to capitalize from the reserves of the Company a sum equal to the amount by which the nominal
value of the shares subject to the Option exceeds the adjusted exercise price; and 

  

	 	(ii)	 applies such sum (if any) in paying up the amount by which the aggregate nominal value of the shares in respect
of which the Option is being exercised exceeds the total exercise price for such shares. 

  

	 	(c)	 Action following adjustment. The Company may take such steps as it may consider necessary to
notify Participants of any adjustment made under Section 8.1(a) and to call in, cancel, endorse, issue or reissue any option certificate or agreement subsequent upon such adjustment. 

  
 5 

	8.2	 Change of Control. 

 

	 	(a)	 Subject to Section 8.2(c) if any person: 

 

	 	(i)	 makes an offer to acquire the whole of the share capital of the Company which is made on a condition such that
if it is satisfied the person making the offer will have Control (having in this Section 8.2 the meaning given in section 719 of the UK Income Tax (Earnings and Pensions) Act 2003) of the Company; or 

 

	 	(ii)	 makes an offer to acquire all of the shares in the Company which are the same class as the Shares; or

  

	 	(iii)	 negotiates a share sale and purchase agreement with the shareholders of the Company which contemplates that
such person will obtain Control of the Company upon completion; or 

  

	 	(iv)	 obtains Control of the Company in any other circumstances or as a result of any other transaction or series of
related transactions; or 

  

	 	(v)	 effects any action, transaction or series of related transactions that the Board determines should be treated
as if it was a change in Control of the Company; 

 the Board may take any one or more of the following actions as to all
or any (or any portion of) outstanding Awards other than Restricted Stock on such terms as the Board determines: (A) upon written notice to a Participant, provide that the Participant’s unexercised or unvested Awards will terminate
immediately prior to the consummation of such change in Control event unless exercised by the Participant within a specified period following the date of such notice, (B) provide that Awards shall be assumed, or substantially equivalent Awards
shall be substituted, by the acquiring or succeeding corporation (or an affiliate thereof), (C) provide that outstanding Awards shall become exercisable in whole or in part prior to or upon such change in Control event, (D) in the event of a
change in Control event under the terms of which holders of shares in the capital of the Company will receive upon consummation thereof a cash payment for each share surrendered in the change in Control event (the “Acquisition
Price”), make 

  
 6 

 or provide for a cash payment to a Participant equal to the excess, if any, of (y) the
Acquisition Price times the number of shares subject to the Participant’s Awards (to the extent the exercise price does not exceed the Acquisition Price) over (z) the aggregate exercise price of all such outstanding Awards and any
applicable tax withholdings, in exchange for the termination of such Awards, (E) provide that, in connection with a liquidation or dissolution of the Company, Awards shall convert into the right to receive liquidation proceeds (if applicable,
net of the exercise price thereof and any applicable tax withholdings) and (F) any combination of the foregoing. In taking any of the actions permitted under this Section 8.2, the Board shall not be obligated by the Plan to treat all
Awards, all Awards held by a Participant, or all Awards of the same type, identically. 
  

	 	(b)	 Upon the occurrence of a change of Control as described at (a) above the Board may determine that
(i) the repurchase and other rights of the Company under each outstanding award of Restricted Stock shall inure to the benefit of the Company’s successor and shall, unless the Board determines otherwise, apply to the cash, securities or
other property which the shares in the capital of the Company was converted into or exchanged for pursuant to such Change of Control in the same manner and to the same extent as they applied to the shares in the capital of the Company subject to
such award of Restricted Stock or (ii) except to the extent specifically provided to the contrary in the instrument evidencing any award of Restricted Stock or any other agreement between a Participant and the Company, all restrictions and
conditions on all awards of Restricted Stock then outstanding shall automatically be deemed terminated or satisfied. 

  

	 	(c)	 Holding Company. Awards shall not become exercisable without the consent of the Board under the
foregoing provisions of this Section 8.2 if the purpose and effect of the transaction is to create a new “holding company” for the Company, such company having substantially the same shareholders and proportionate shareholdings as
those of the Company immediately prior to the transaction. 

  

	 	(d)	 Listing. Notwithstanding anything herein to the contrary, in no event shall the listing of any
class of the Company’s shares on a public securities exchange be considered a change in Control of the Company, unless the Board specifically determines otherwise at the time of such listing. 

 

	8.3	 Sale of Assets. On a sale of substantially all of the assets of the Company, the provisions of
Section 8.2 (Change of Control) shall apply to the extent that the Board may take any of the actions described at (A), (B), (C), (D), (E) or (F) therein in relation to outstanding Awards. 

  
 7 

	9.	 GENERAL PROVISIONS APPLICABLE TO AWARDS 

 

	9.1	 Transferability of Awards. Except as the Board may otherwise determine or provide in an Award,
Awards shall not be sold, assigned, transferred, pledged or otherwise encumbered by the person to whom they are granted, either voluntarily or by operation of law, except by will or the laws of descent and distribution or, other than in the case of
an Incentive Stock Option, pursuant to a qualified domestic relations order, and, during the life of the Participant, shall be exercisable only by the Participant. References to a Participant, to the extent relevant in the context, shall include
references to authorized transferees. 

  

	9.2	 Documentation. Each Award shall be evidenced in such form (written, electronic or otherwise) as
the Board shall determine. Each Award may contain terms and conditions in addition to those set forth in the Plan. 

  

	9.3	 Board Discretion. Except as otherwise provided by the Plan, each Award may be made alone or in
addition or in relation to any other Award. The terms of each Award need not be identical, and the Board need not treat Participants uniformly. 

  

	9.4	 Termination of Status. The Board shall determine the effect on an Award of the disability, death,
termination or other cessation of employment, authorized leave of absence or other change in the employment or other status of a Participant and the extent to which, and the period during which, the Participant, or the Participant’s legal
representative, conservator, guardian or Designated Beneficiary, may exercise rights under the Award. 

  

	9.5	 Withholding. Each Participant shall pay to the Company, or make provision satisfactory to the
Board for payment of, any taxes required by law to be withheld in connection with Awards to such Participant no later than the date of the event creating the tax liability. 

 

	9.6	 Amendment of Award. The Board may amend, modify or terminate any outstanding Award, including but
not limited to, substituting therefor another Award of the same or a different type, changing the date of exercise or realization, and converting an Incentive Stock Option to a Nonstatutory Stock Option. The Participant’s consent to such action
shall be required unless 

  

	 	(i)	 the Board determines that the action, taking into account any related action, would not materially and
adversely affect the Participant’s rights under the Plan or (ii) the change is permitted under Section 8 hereof. 

  

	9.7	 Conditions on Delivery of Shares. The Company will not be obligated to deliver any shares
pursuant to the Plan or to remove restrictions from shares previously delivered under the Plan until (i) all conditions of the Award have been met or removed to the satisfaction of the Company, (ii) in the opinion of the Company’s
counsel, all other legal matters in connection with the issuance and delivery of such shares have been satisfied, including any applicable securities laws and any applicable stock exchange or stock market rules and regulations, and

  
 8 

	 	(i)	 the Participant has executed and delivered to the Company such representations or agreements as the Company may
consider appropriate to satisfy the requirements of any applicable laws, rules or regulations. 

  

	9.8	 Acceleration. The Board may at any time provide that any Award shall become immediately
exercisable in full or in part, free of some or all restrictions or conditions, or otherwise realizable in full or in part, as the case may be. 

  

	10.	 MISCELLANEOUS 

 

	10.1	 No Right to Employment or Other Status. No person shall have any claim or right to be granted an
Award, and the grant of an Award shall not be construed as giving a Participant the right to continued employment or any other relationship with the Company. The Company expressly reserves the right at any time to dismiss or otherwise terminate its
relationship with a Participant free from any liability or claim under the Plan, except as expressly provided in the applicable Award. 

  

	10.2	 No Rights as Shareholder. Subject to the provisions of the applicable Award, no Participant or
Designated Beneficiary shall have any rights as a shareholder with respect to any shares in the capital of the Company to be distributed with respect to an Award until becoming the record holder of such shares. 

 

	10.3	 Effective Date and Term of Plan. The Plan shall become effective on the date on which it is
adopted by the Board. No Awards shall be granted under the Plan after the expiration of 10 years from the earlier of (i) the date on which the Plan was adopted by the Board or (ii) the date the Plan was approved by the Company’s
shareholders, but Awards previously granted may extend beyond that date. 

  

	10.4	 Amendment of Plan. The Board may amend, suspend or terminate the Plan or any portion thereof at
any time; provided that if at any time the approval of the Company’s shareholders is required as to any modification or amendment under Section 422 of the Code or any successor provision with respect to Incentive Stock Options, the Board
may not effect such modification or amendment without such approval. Unless otherwise specified in the amendment, any amendment to the Plan adopted in accordance with this Section 10.4 shall apply to, and be binding on the holders of, all
Awards outstanding under the Plan at the time the amendment is adopted, provided the Board determines that such amendment does not materially and adversely affect the rights of Participants under the Plan. 

  
 9 

	10.5	 Authorization of Sub-Plans. The Board may from time to
time establish one or more sub- plans under the Plan for purposes of satisfying applicable US blue sky, securities or tax laws of various jurisdictions. The Board shall establish such sub-plans by adopting supplements to this Plan containing (i) such limitations on the Board’s discretion under the Plan as the Board deems necessary or desirable or (ii) such additional terms and
conditions not otherwise inconsistent with the Plan as the Board shall deem necessary or desirable. All supplements adopted by the Board shall be deemed to be part of the Plan, but each supplement shall apply only to Participants within the affected
jurisdiction and the Company shall not be required to provide copies of any supplement to Participants in any jurisdiction which is not the subject of such supplement. 

 

	10.6	 Compliance with Code Section 409A. No Award shall provide for deferral of
compensation that does not comply with Section 409A of the Code, unless the Board, at the time of grant, specifically provides that the Award is not intended to comply with Section 409A of the Code. The Company shall have no liability to a
Participant, or any other party, if an Award that is intended to be exempt from, or compliant with, Section 409A is not so exempt or compliant or for any action taken by the Board. 

 

	10.7	 Data Privacy. 

For the purpose of operating the Plan in the European Union, the Company will collect and process information relating to Participants in
accordance with the privacy notice which is provided to each Participant. 
  

	10.8	 Governing Law. The provisions of the Plan and all Awards made hereunder shall be governed by and
interpreted in accordance with English law. 

  
 10 

 Rockley Photonics Limited 

2013 EQUITY INCENTIVE PLAN 

CALIFORNIA SUPPLEMENT 
 Pursuant to
Section 10.5 of the Plan, the Board has adopted this supplement for purposes of satisfying the requirements of Section 25102(o) of the California Law: 

Any Awards granted under the Plan to a Participant who is a resident of the State of California on the date of grant (a “California
Participant”) shall be subject to the following additional limitations, terms and conditions: 
  

	1.	 ADDITIONAL LIMITATIONS ON OPTIONS. 

 

	1.1	 Maximum Duration of Options. No Options granted to California Participants shall have a term in
excess of 10 years measured from the Option grant date. 

  

	1.2	 Minimum Exercise Period Following Termination. Unless a California Participant’s employment
is terminated for cause (as defined by applicable law, the terms of the Plan or option grant or a contract of employment), in the event of termination of employment of such Participant, such Participant shall have the right to exercise an Option, to
the extent that such Participant is entitled to exercise such Option on the date employment terminated, until the earlier of: (i) at least six months from the date of termination, if termination was caused by such Participant’s death or
disability, (ii) at least 30 days from the date of termination, if termination was caused other than by such Participant’s death or disability and (iii) the Option expiration date. 

 

	2.	 ADDITIONAL LIMITATIONS FOR OTHER STOCK-BASED AWARDS 

The terms of all Awards granted to a California Participant under Section 7 of the Plan shall comply, to the extent applicable, with
Sections 260.140.42, 260.140.45 and 260.140.46 of the California Code of Regulations. 
  

	3.	 ADDITIONAL LIMITATIONS ON TIMING OF AWARDS 

No Award granted to a California Participant shall become exercisable, vested or realizable, as applicable to such Award, unless the Plan has
been approved by the holders of a majority of the Company’s outstanding voting securities by the later of (i) within 12 months before or after the date the Plan was adopted by the Board, or (ii) prior to or within 12 months of the
granting of any Award to a California Participant. 

  
 11 

	4.	 ADDITIONAL RESTRICTION REGARDING RECAPITALIZATIONS, STOCK SPLITS, ETC. 

For purposes of Section 8.1(a) of the Plan, in the event of a stock split, reverse stock split, stock dividend, recapitalization,
combination, reclassification or other distribution of the Company’s securities underlying the Award without the receipt of consideration by the Company, the number of securities purchasable, and in the case of Options, the exercise price of
such Options, must be proportionately adjusted. 
  

	5.	 ADDITIONAL LIMITATIONS ON TRANSFERABILITY OF AWARDS 

Notwithstanding the provisions of Section 9.1 of the Plan, an Award granted to a California Participant may not be transferred to an
executor or guardian upon the disability of the Participant. 

  
 12 

 ROCKLEY PHOTONICS LIMITED 

Non-Qualified Option Agreement 

Granted Under 2013 Equity Incentive Plan 

THIS AGREEMENT is made [ date ] 
 BETWEEN: 

 

	(1)	 ROCKLEY PHOTONICS LIMITED whose registered office is at C/o Cooley (UK) LLP, 10th Floor, Dashwood, 69 Old Broad Street, London, EC2M 1QS (registered in England and Wales under No 08683015 (the “Company”); and 

 

	(2)	 [NAME] (the “Participant”) 

WHEREAS: 
  

	(A)	 The Company has agreed to grant the Participant an option to acquire ordinary shares in the capital of the
Company. 

  

	(B)	 The option is subject to the terms of this agreement and the Company’s 2013 Equity Incentive Plan (the
“Plan”), a copy of which is available from the Company Secretary. 

  

	1.	 Grant of Option. 

This agreement evidences the grant by the Company on [date] (the “Grant Date”) to [Name], an employee of the Company or one of
its wholly owned subsidiaries (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Plan, a total of [number of shares] ordinary shares of £0.00001 each in the capital of
the Company (the “Shares”) at $[share price] per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., GMT, on the day immediately preceding the 10th
anniversary of the Grant Date (the “Final Exercise Date”). 
 Except as otherwise indicated by the context, the term
“Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms. 

It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the
Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). 
  

	2.	 Vesting Schedule. 

This option will become exercisable (“vest”) as to 25% of the original number of Shares on the first anniversary of the Grant
Date and as to an additional 2.0833% of the original number of Shares each successive month following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date. Any fraction of a Share resulting from a computation made
pursuant to this Section 2 shall be rounded to the nearest whole Share. 

 The right of exercise shall be cumulative so that to the extent the option is not exercised
in any period to the maximum extent permissible it shall continue to be exercisable, in whole or in part, with respect to all Shares for which it is vested until the earlier of the Final Exercise Date or the termination of this option under
Section 3 hereof or the Plan. 
  

	3.	 Exercise of Option. 

a. Form of Exercise. Each election to exercise this option shall be in writing, in the form of Exhibit A, signed by the Participant, and
received by the Company at its principal office, accompanied by this agreement, and payment in full in the manner provided in the Plan. The Participant may purchase fewer than the number of shares covered hereby, provided that no partial exercise of
this option may be for any fractional share. 
 b. Continuous Relationship with the Company Required. Except as otherwise provided in
this Section 3, this option may not be exercised unless the Participant, at the time he or she exercises this option, is, and has been at all times since the Grant Date, an employee of or consultant to the Company or any other entity the
employees of which are eligible to receive option grants under the Plan (an “Eligible Participant”). 
 c. Termination of
Relationship with the Company. If the Participant ceases to be an Eligible Participant for any reason, then, except as provided in paragraphs (d) and (e) below, the right to exercise this option shall terminate 90 days after such cessation
(but in no event after the Final Exercise Date), provided that this option shall be exercisable only to the extent that the Participant was entitled to exercise this option on the date of such cessation. Notwithstanding the foregoing, if the
Participant, prior to the Final Exercise Date, violates the non-competition or confidentiality provisions of any employment contract, confidentiality and nondisclosure agreement or other agreement between the
Participant and the Company, the right to exercise this option shall terminate immediately upon written notice to the Participant from the Company describing such violation. 

d. Exercise Period Upon Death. If the Participant dies prior to the Final Exercise Date while he or she is an Eligible Participant, this
option shall be exercisable, within the period of one year following the date of death of the Participant, by his or her personal representative, provided that this option shall be exercisable only to the extent that this option was exercisable by
the Participant on the date of his or her death, and further provided that this option shall not be exercisable after the Final Exercise Date. 

e. Discharge for Cause. If the Participant, prior to the Final Exercise Date, is discharged by the Company for “cause” (as
defined below), the right to exercise this option shall terminate immediately upon the effective date of such discharge. “Cause” shall mean willful misconduct by the Participant or willful failure by the Participant to perform his
or her responsibilities to the Company (including, without limitation, any material breach by the Participant of any provision of any employment, nondisclosure, non-competition or other similar agreement
between the Participant and the Company), as determined by the Company, which determination shall be conclusive. The Participant shall be considered to have been discharged for “Cause” if the Company determines, within 30 days after the
Participant’s resignation, that discharge for cause was warranted. 
 f. Conditions on Delivery of Shares. The Company will not
be obligated to deliver any Shares pursuant to this agreement until all conditions of this option have been met to the satisfaction of the Company. 

 g. Restriction on Voting. The Participant agrees that in relation to the Shares
acquired on exercise of this option, the Participant shall exercise any voting rights attaching to such Shares as directed by the Board of Directors of the Company. 
  

	4.	 Tax Matters. 

a. Withholding. No Shares will be issued pursuant to the exercise of this option unless and until the Participant pays to the Company,
or makes provision satisfactory to the Company for payment of any US federal, state or local withholding taxes or UK income tax and national insurance contributions required by law to be withheld in respect of this option or which the Participant
has agreed or elected to bear. 
 b. Indemnity. The Participant hereby indemnifies the Company, his employer and each parent or
subsidiary of the Company against all and any US federal, state or local withholding taxes or UK income tax and national insurance contributions which arise or may arise in connection with this option and the ordinary shares issued or transferred to
the Participant pursuant to the exercise of this option in whole or in part. 
  

	5.	 Nontransferability of Option. 

This option may not be sold, assigned, transferred, pledged or otherwise encumbered by the Participant, either voluntarily or by operation of
law, except to his or her personal representatives in the event of his or her death, and, during the lifetime of the Participant, this option shall be exercisable only by the Participant. 

 

	6.	 No Right to Employment etc. 

a. The grant of options under the Plan is made at the discretion of the Board and the Plan may be suspended or terminated by the Company at any
time. The grant of an option in one year or at one time does not in any way entitle the Participant to an option grant in the future. The Plan is wholly discretionary and is not to be considered part of the Participant’s normal or expected
compensation subject to severance, resignation, redundancy or similar compensation. The value of the option is an extraordinary item of compensation which is outside the scope of the Participant’s employment contract (if any). 

b. Nothing in this agreement or the Plan shall confer upon the Participant any right to continue in service for any period of specific duration
or interfere with or otherwise restrict in any way the rights of the Company (or any company employing or retaining the Participant) or of the Participant, which rights are hereby expressly reserved by each, to terminate the Participant’s
service at any time for any reason, with or without cause. 
 c. The rights and obligations of the Participant under the terms of his office,
employment or consultancy with the Company, any past or present subsidiary, or associated or affiliate company of the Company shall not be affected by his participation in the Plan or the grant of this option or any right which he may have to
participate therein, and the Participant hereby waives all and any rights to compensation or damages in consequence of the termination of his office, employment or consultancy with any such company for any reasons whatsoever (whether lawful or
unlawful and including, without prejudice to the generality of the foregoing, in circumstances giving rise to a claim for wrongful dismissal) insofar as those rights arise or may arise from his ceasing to have rights under or being entitled to
exercise this option as a result of such termination, or from the loss or diminution in value of such rights or entitlements. 

	7.	 Data Protection 

The Participant agrees to the receipt, holding and processing of information in connection with the grant, vesting, exercise, taxation and
general administration of the Plan and this option by the Company or any subsidiary of the Company and any of their advisers or agents and to the transmission of such information outside of the European Economic Area for this purpose. 

 

	8.	 Provisions of the Plan. 

This option is subject to the provisions of the Plan, a copy of which is furnished to the Participant with this option. 

 

	9.	 Third Party Rights. 

The Contracts (Rights of Third Parties) Act 1999 shall not apply to this option and no person other than parties hereto shall have any rights
under it nor shall it be enforceable under that Act by any person other than the parties to it. 

 IN WITNESS WHEREOF the parties have executed this Option Agreement as a Deed on the day and year
first above written 
  

					
	EXECUTED as a DEED by	 	)	  	
	ROCKLEY PHOTONICS LIMITED	 	)	  	
	acting by:	 	)	  	
		 	)	  	  

		 	)	  	Director
		 	)	  	
		 	)	  	  

		 	)	  	Director/Secretary
	EXECUTED as a DEED by	 	)	  	
	[NAME] in the presence of:	 	)	  	  

		 	)	  	Participant

  

			
	Witness signature:
	  

	Witness name:
	  

	Witness address:
	  

	  

 EXHIBIT A 

NOTICE OF OPTION EXERCISE 

Date:                 1 
 Rockley Photonics Limited 

Attention: Company Secretary 
 Dear Sir or Madam: 

I am the holder of an Option granted to me under the Rockley Photonics Limited (the “Company”) 2013 Equity Incentive Plan on
                 2 for the purchase of
                 3 ordinary shares in the capital of the Company at a purchase price of £
                 4 per share. 

I hereby exercise my option to purchase                 
5 ordinary shares in the capital of the Company (the “Shares”), for which I have enclosed a cheque for £
                 in favor of Rockley Photonics Limited as payment in full of the option price. 

I request that I am registered as the holder of such ordinary shares and a definitive certificate for such shares be sent to me at my risk to
the address below: 
  

			
	Name(s): 	  	  

	Address: 	  	  

		  	  

	Tax I.D. # / National	  	  

	Insurance No:	  	

  

	
	 Yours faithfully

	  

	 (Signature)

	

  

	1 	 Enter the date of exercise. 

 

	2 	 Enter the date of grant. 

 

	3 	 Enter the total number of Shares for which the option was granted. 

 

	4 	 Enter the option exercise price per Share. 

 

	5 	 Enter the number of Shares to be purchased upon exercise of all or part of the option. 

 ROCKLEY PHOTONICS LIMITED 

Enterprise Management Incentive Option Agreement 

Granted Under 2013 Equity Incentive Plan 

THIS AGREEMENT is made day of 
 BETWEEN: 

 

	(1)	 ROCKLEY PHOTONICS LIMITED whose registered office is at C/o Cooley (UK) LLP, 10th Floor, Dashwood, 69
Old Broad Street, London, EC2M 1QS (registered in England and Wales under No 08683015 (the “Company”); and 

  

	(2)	 (the “Participant”) 

 

	WHEREAS:	 

  

	(A)	 The Board (as defined below) considers that the Company is a qualifying company as defined in Part 3 of
Schedule 5 to the UK Income Tax (Earnings and Pensions) Act 2003 (“Schedule 5”). In this agreement, the “Board” shall have the same meaning as it carries in the Company’s 2013 Equity Incentive Plan (the
“Plan”), a copy of which is available from the Company Secretary. 

  

	(B)	 The Participant is an eligible employee as defined in Part 4 of Schedule 5. 

 

	(C)	 The Board considers that the grant of this option to the Participant is for commercial reasons in order to
recruit or retain the Participant and not as part of a scheme or arrangement the main purpose, or one of the main purposes, of which is the avoidance of tax. 

  

	(D)	 The Board considers that the total Market Value (as defined below) of shares in the Company in respect of which
unexercised options (granted in respect of the Company’s shares which qualify or are intended to qualify as enterprise management incentive options under the terms of Schedule 5 (“EMI Options”)) subsist does not exceed
£3 million or such other value as shall be specified at that time in paragraph 7 of Schedule 5. In this agreement, “Market Value” shall be determined in accordance with Part VIII of the Taxation of Chargeable Gains Act
1992. 

  

	(E)	 The Market Value (as at the date of grant) of the Shares (as defined below) which the Participant could acquire
or has acquired or could have acquired by the exercise of: 

  

	 	(i)	 this option, and/or 

  

	 	(ii)	 any other EMI Options granted to him under the Plan or otherwise by reason of his employment with any Group
Company (as defined below) in the preceding three years (whether or not exercised or released), and/or     

	 	(iii)	 any unexercised options to acquire shares under a scheme approved under Schedule 4 to the UK Income Tax
(Earnings and Pensions) Act 2003 granted to him by reason of his employment with any Group Company in the preceding three years, 

does not exceed £250,000 or such other limit as may be imposed from time to time by Schedule 5. The term “Group
Company” shall include any of the Company’s present or future parent or subsidiary corporations, and any present or future subsidiary corporations of any such present or future parent corporations, as defined in Sections 424(e) or
(f) of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). 
  

	(F)	 The Company has agreed to grant the Participant an enterprise management incentive option to acquire ordinary
shares in the capital of the Company in accordance with the terms of Schedule 5 and on the terms set out in this agreement and the Plan. 

  

	(G)	 The restrictions to which the Shares may be subject are set out in (i) the Company’s Articles of
Association as amended from time to time (a copy of which is available from the Company Secretary), and (ii) this agreement and the Plan generally. 

  

	1.	 Grant of Option.  

This agreement evidences the grant by the Company on (the “Grant Date”) to , an employee of the Company or one of its wholly
owned subsidiaries (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Plan, a total of ordinary shares of £0.00001 each in the capital of the Company (the
“Shares”) at per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., GMT, on the day immediately preceding the 10th anniversary of the Grant Date (the “Final Exercise Date”). 

Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person
who acquires the right to exercise this option validly under its terms. 
 It is intended that this option is a qualifying option under
Schedule 5. This option is granted under the provision of Schedule 5. 
 By executing this agreement, the Participant declares that he works
for the Company or a Group Company for at least 25 hours a week or 75% of his working time. 
 The Company shall within 92 days of the Grant
Date notify the grant of this option to HM Revenue & Customs. Such notification shall be in the form required or authorized by HM Revenue & Customs and will contain, or be supported by, such information as HM Revenue &
Customs may from time to time require. 
  

	2.	 Vesting Schedule. 

This option will become exercisable (“vest”) as to 25% of the original number of Shares on the first anniversary of the Grant
Date and as to an additional 2.0833% of the original number of Shares each successive month following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date. Any fraction of a Share resulting from a computation made
pursuant to this Section 2 shall be rounded to the nearest whole Share. 

 The right of exercise shall be cumulative so that to the extent the option is not exercised
in any period to the maximum extent permissible it shall continue to be exercisable, in whole or in part, with respect to all Shares for which it is vested until the earlier of the Final Exercise Date or the termination of this option under
Section 3 hereof or the Plan. 
  

	3.	 Exercise of Option. 

(a) Form of Exercise. Each election to exercise this option shall be in writing, in the form of the Exhibit, signed by the Participant,
and received by the Company at its principal office, accompanied by this agreement, and payment in full in the manner provided in the Plan. The Participant may purchase fewer than the number of shares covered hereby, provided that no partial
exercise of this option may be for any fractional share. 
 (b) Continuous Relationship with the Company Required. Except as otherwise
provided in this Section 3, this option may not be exercised unless the Participant, at the time he or she exercises this option, is, and has been at all times since the Grant Date, an employee of the Company or any other entity the employees
of which are eligible to receive option grants under the Plan (an “Eligible Participant”). 
 (c) Termination of
Relationship with the Company. If the Participant ceases to be an Eligible Participant for any reason, then, except as provided in paragraph (d) below, the right to exercise this option shall terminate 90 days after such cessation (but in
no event after the Final Exercise Date), provided that this option shall be exercisable only to the extent that the Participant was entitled to exercise this option on the date of such cessation. 

(d) Exercise Period Upon Death. If the Participant dies prior to the Final Exercise Date while he or she is an Eligible Participant,
this option shall be exercisable, within the period of one year following the date of death of the Participant, by his or her personal representative, provided that this option shall be exercisable only to the extent that this option was exercisable
by the Participant on the date of his or her death, and further provided that this option shall not be exercisable after the Final Exercise Date. 

(e) Conditions on Delivery of Shares. The Company will not be obligated to deliver any Shares pursuant to this agreement until all
conditions of this option have been met to the satisfaction of the Company. 
 (f) Joint Election. Unless the Board permits otherwise,
this option may not be exercised unless and until the Company (or any Group Company) has received from the Participant a duly completed joint election with the Company, his employer or other company (in the form prescribed by the Board)
(“Joint Election”) to the effect that the Participant will become liable, so far as permissible by law, for the whole of any secondary Class 1 national insurance contributions which may arise in connection with this option and
the Shares which may or are acquired on the exercise of this option. 

 (g) Restricted Shares Election. Unless the Board permits otherwise, this option may
not be exercised unless and until the Participant enters into a joint election under Section 431(1) of the Income Tax (Earnings and Pensions) Act 2003 (in the form prescribed by the Board) for the full disapplication of Chapter 2 of Part 7 of
that Act. 
 (h) Restriction on Voting. The Participant agrees that in relation to the Shares acquired on exercise of this option, the
Participant shall exercise any voting rights attaching to such Shares as directed by the Board of Directors of the Company. 
  

	4.	 Tax Matters. 

(a) Withholding. No Shares will be issued pursuant to the exercise of this option unless and until the Participant pays to the Company,
or makes provision satisfactory to the Company for payment of any UK income tax and national insurance contributions required by law to be withheld in respect of this option or which the Participant has agreed or elected to bear. 

(b) Indemnity. The Participant hereby indemnifies the Company, his employer and each parent or subsidiary of the Company against all and
any UK income tax and national insurance contributions which arise or may arise in connection with this option and the ordinary shares issued or transferred to the Participant pursuant to the exercise of this option in whole or in part. 

(c) Tax status. Neither the Company nor any parent or subsidiary of the Company shall have any liability to the Participant if this
option (or any part thereof) is not or ceases to be a qualifying option under schedule 5 to the Income Tax (Earnings and Pensions) Act 2003. 
  

	5.	 Nontransferability of Option. 

This option may not be sold, assigned, transferred, pledged or otherwise encumbered by the Participant, either voluntarily or by operation of
law, except to his or her personal representatives in the event of his or her death, and, during the lifetime of the Participant, this option shall be exercisable only by the Participant. 

 

	6.	 No Right to Employment etc. 

(a) The grant of options under the Plan is made at the discretion of the Board and the Plan may be suspended or terminated by the Company at
any time. The grant of an option in one year or at one time does not in any way entitle the Participant to an option grant in the future. The Plan is wholly discretionary and is not to be considered part of the Participant’s normal or expected
compensation subject to severance, resignation, redundancy or similar compensation. The value of the option is an extraordinary item of compensation which is outside the scope of the Participant’s employment contract (if
any).     
 (b) Nothing in this agreement or the Plan shall confer upon the Participant any right to continue in service
for any period of specific duration or interfere with or otherwise restrict in any way the rights of the Company (or any company employing or retaining the Participant) or of the Participant, which rights are hereby expressly reserved by each, to
terminate the Participant‘s service at any time for any reason, with or without cause. 

 (c) The rights and obligations of the Participant under the terms of his office or
employment with the Company, any past or present subsidiary, or associated or affiliate company of the Company shall not be affected by his participation in the Plan or the grant of this option or any right which he may have to participate therein,
and the Participant hereby waives all and any rights to compensation or damages in consequence of the termination of his office or employment with any such company for any reasons whatsoever (whether lawful or unlawful and including, without
prejudice to the generality of the foregoing, in circumstances giving rise to a claim for wrongful dismissal) insofar as those rights arise or may arise from his ceasing to have rights under or being entitled to exercise this option as a result of
such termination, or from the loss or diminution in value of such rights or entitlements. 
  

	7.	 Data Protection 

The Participant agrees to the receipt, holding and processing of information in connection with the grant, vesting, exercise, taxation and
general administration of the Plan and this option by the Company or any subsidiary of the Company and any of their advisers or agents and to the transmission of such information outside of the European Economic Area for this purpose. 

 

	8.	 Provisions of the Plan. 

This option is subject to the provisions of the Plan, a copy of which is furnished to the Participant with this option. 

 

	9.	 Third Party Rights. 

The Contracts (Rights of Third Parties) Act 1999 shall not apply to this option and no person other than parties hereto shall have any rights
under it nor shall it be enforceable under that Act by any person other than the parties to it.     

 IN WITNESS WHEREOF the parties have executed this Option Agreement as a Deed on the day and year
first above written 
  
  

					
	EXECUTED as a DEED by ROCKLEY	  	)	  	
	PHOTONICS LIMITED	  	)	  	
	acting by:	  	)	  	  

		  	)	  	Director
		  	)	  	
		  	)	  	
		  	)	  	  

		  	)	  	Director/Secretary
			
	EXECUTED as a DEED by	  	)	  	
	in the presence of:	  	)	  	  

		  	)	  	Participant

  

	
	Witness signature:
	
	  

	
	Witness name:
	
	  

	
	Witness address:
	
	  

	
	  

 EXHIBIT 

NOTICE OF EMI OPTION EXERCISE 

Date:                     1 
 Rockley Photonics Limited 

Attention: Company Secretary 
 Dear Sir or Madam: 

I am the holder of an EMI Option granted to me under the Rockley Photonics Limited (the “Company”) 2013 Equity Incentive Plan
on                      2 for the purchase of
                     3 ordinary shares in the capital of the Company at a purchase
price of £                      4 per share. 

I hereby exercise my option to purchase
                     5 ordinary shares in the capital of the Company (the
“Shares”), for which I have enclosed a cheque for £ in favor of Rockley Photonics Limited as payment in full of the option price. 

I request that I am registered as the holder of such ordinary shares and a definitive certificate for such shares be sent to me at my risk to
the address below: 
  

					
			
	 Name(s):
	  	  
	  	
			
		  	  
	  	
			
	 Address:
	  	  
	  	
			
	 National Insurance No:
	  	  
	  	
			
	Yours faithfully	  		  	
			
	  
	  		  	
	(Signature)	  		  	

  

	1 	 Enter the date of exercise. 

	2 	 Enter the date of grant. 

	3 	 Enter the total number of Shares for which the option was granted. 

	4 	 Enter the option exercise price per Share. 

	5 	 Enter the number of Shares to be purchased upon exercise of all or part of the option. 

 ROCKLEY PHOTONICS LIMITED 

Nonstatutory Stock Option Agreement 

Granted Under 2013 Equity Incentive Plan 
  

	1.	 Grant of Option. 

This agreement evidences the grant by Rockley Photonics Limited, a company registered in England and Wales under No. 08683015 whose
registered address is 5th Floor, Alder Castle, 10 Noble Street, London EC2V 7QJ (the “Company”), on __________, 201[ ] (the “Grant Date”) to [____________________________] (the “Participant”), of an option to purchase,
in whole or in part, on the terms provided herein and in the Company’s 2013 Equity Incentive Plan (the “Plan”), a total of [__________] ordinary shares, nominal value £0.00001 per share in the capital of the Company (the
“Shares”), of the Company (“Ordinary Shares”) at $[_____] per Share.1 Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on [___________] (the
“Final Exercise Date”). 
 It is intended that the option evidenced by this agreement shall not be an incentive stock option as
defined in Section 422 of the United States Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in
this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms. 
  

	2.	 Vesting Schedule. 

This option will become exercisable (“vest”) as to ___% of the original number of Shares on the [first] anniversary of the Vesting
Commencement Date (as defined below) and as to an additional ___% of the original number of Shares at the end of each successive [three-month] period following the first anniversary of the Vesting Commencement Date until the [fourth] anniversary of
the Vesting Commencement Date. The Vesting Commencement Date shall be ________________________. 
 The right of exercise shall be cumulative
so that to the extent the option is not exercised in any period to the maximum extent permissible it shall continue to be exercisable, in whole or in part, with respect to all Shares for which it is vested until the earlier of the Final Exercise
Date or the termination of this option under Section 3 hereof or the Plan. 
  

	3.	 Exercise of Option. 

(a) Form of Exercise. Each election to exercise this option shall be in writing, signed by the Participant, and received by the Company
at its principal office, accompanied by this agreement, and payment in full in the manner provided in the Plan. The Participant may purchase less than the number of shares covered hereby, provided that no partial exercise of this option may be for
any fractional share. 
  

	1 	 This must be at least 100% of the fair market value of the Ordinary Shares on the date of grant to avoid
adverse tax consequences to the Company and the Participant under Section 409A of the Code. 

	4.	 Continuous Relationship with the Company Required. Except as otherwise provided in this Section 3,
this option may not be exercised unless the Participant, at the time he or she exercises this option, is, and has been at all times since the Grant Date, an employee or officer of, or consultant or advisor to, the Company or any parent or subsidiary
of the Company as defined in Section 424(e) or (f) of the Code (an “Eligible Participant”). 

 (a)
Termination of Relationship with the Company. If the Participant ceases to be an Eligible Participant for any reason, then, except as provided in paragraphs (d) and (e) below, the right to exercise this option shall terminate three
months after such cessation (but in no event after the Final Exercise Date), provided that this option shall be exercisable only to the extent that the Participant was entitled to exercise this option on the date of such cessation. Notwithstanding
the foregoing, if the Participant, prior to the Final Exercise Date, violates the non-competition or confidentiality provisions of any employment contract, confidentiality and nondisclosure agreement or other
agreement between the Participant and the Company, the right to exercise this option shall terminate immediately upon such violation. 
 (b)
Exercise Period Upon Death or Disability. If the Participant dies or becomes disabled (within the meaning of Section 22(e)(3) of the Code) prior to the Final Exercise Date while he or she is an Eligible Participant and the Company has
not terminated such relationship for “cause” as specified in paragraph (e) below, this option shall be exercisable, within the period of one year following the date of death or disability of the Participant, by the Participant (or in
the case of death by an authorized transferee), provided that this option shall be exercisable only to the extent that this option was exercisable by the Participant on the date of his or her death or disability, and further provided that this
option shall not be exercisable after the Final Exercise Date. 
 (c) Termination for Cause. If, prior to the Final Exercise Date, the
Participant’s employment is terminated by the Company for Cause (as defined below), the right to exercise this option shall terminate immediately upon the effective date of such termination of employment. If, prior to the Final Exercise Date,
the Participant is given notice by the Company of the termination of his or her employment by the Company for Cause, and the effective date of such employment termination is subsequent to the date of delivery of such notice, the right to exercise
this option shall be suspended from the time of the delivery of such notice until the earlier of (i) such time as it is determined or otherwise agreed that the Participant’s employment shall not be terminated for Cause as provided in such
notice or (ii) the effective date of such termination of employment (in which case the right to exercise this option shall, pursuant to the preceding sentence, terminate upon the effective date of such termination of employment). If the
Participant is party to an employment or severance agreement with the Company that contains a definition of “cause” for termination of employment, “Cause” shall have the meaning ascribed to such term in such agreement. Otherwise,
“Cause” shall mean willful misconduct by the Participant or willful failure by the Participant to perform his or her responsibilities to the Company (including, without limitation, breach by the Participant of any provision of any
employment, consulting, advisory, nondisclosure, non-competition or other similar agreement between the Participant and the Company), as determined by the Company, which determination shall be conclusive. The
Participant’s employment shall be considered to have been terminated for Cause if the Company determines, within 30 days after the Participant’s resignation, that termination for Cause was warranted. 

	5.	 Company Right of First Refusal.2

 (a) Notice of Proposed Transfer. If the Participant proposes to sell, assign, transfer, pledge, hypothecate or
otherwise dispose of, by operation of law or otherwise (collectively, “transfer”) any Ordinary Shares acquired upon exercise of this option, then the Participant shall first give written notice of the proposed transfer (the “Transfer
Notice”) to the Company. The Transfer Notice shall name the proposed transferee and state the number of such Ordinary Shares the Participant proposes to transfer (the “Offered Shares”), the price per share and all other material terms
and conditions of the transfer. 
 (b) Company Right to Purchase. For 30 days following its receipt of such Transfer Notice, the
Company shall have the option to purchase all or part of the Offered Shares at the price and upon the terms set forth in the Transfer Notice. In the event the Company elects to purchase all or part of the Offered Shares, it shall give written notice
of such election to the Participant within such 30-day period. Within 10 days after his or her receipt of such notice, the Participant shall tender to the Company at its principal offices the certificate or
certificates representing the Offered Shares to be purchased by the Company, duly endorsed in blank by the Participant or with duly endorsed stock powers attached thereto, all in a form suitable for transfer of the Offered Shares to the Company.
Promptly following receipt of such certificate or certificates, the Company shall deliver or mail to the Participant a check in payment of the purchase price for such Offered Shares; provided that if the terms of payment set forth in the Transfer
Notice were other than cash against delivery, the Company may pay for the Offered Shares on the same terms and conditions as were set forth in the Transfer Notice; and provided further that any delay in making such payment shall not invalidate the
Company’s exercise of its option to purchase the Offered Shares. 
 (c) Shares Not Purchased By Company. If the Company does not
elect to acquire all of the Offered Shares, the Participant may, within the 30-day period following the expiration of the option granted to the Company under subsection (b) above, transfer the Offered
Shares which the Company has not elected to acquire to the proposed transferee, provided that such transfer shall not 
  

	2	 Please note the following considerations relating to the Company Right of First Refusal: 

 

	 	•	 	 This section is often used when the Company is not currently publicly traded. Some companies may prefer a more
complete stock restriction agreement which would include the right of first refusal included in this agreement, as well as other restrictions. In that case, this section should be replaced with a section that provides the Participant, as a condition
to exercising this option, must enter into a separate stock restriction agreement. 

  

	 	•	 	 This right of first refusal can be made more pro-company by
(i) allowing the Company to pay the exercise price using a promissory note and (ii) extending the period of time prior to which the Company must respond to the Transfer Notice. 

 

	 	•	 	 In addition to a right of first refusal, consideration should be given to the appropriateness of adding a Company
Right of Repurchase. Such a right could provide for (i) repurchase at fair market value (this type of right is frequently limited to a short period of time after termination of employment and typically expires upon an IPO) and/or
(ii) repurchase at the original exercise price if the optionee violates a non-competition or confidentiality agreement. 

 

	 	•	 	 Some companies insert provisions prohibiting transfers to competitors of the Company. 

	 	•	 	 This right of first refusal permits the Company to buy, at its option, all or any portion of the Offered Shares.
Option recipients would prefer a provision that requires the Company to buy all or none of the Offered Shares. 

 
be on terms and conditions more favorable to the transferee than those contained in the Transfer Notice. Notwithstanding any of the above, all Offered Shares transferred pursuant to this
Section 4 shall remain subject to the right of first refusal set forth in this Section 4 and such transferee shall, as a condition to such transfer, deliver to the Company a written instrument confirming that such transferee shall be bound
by all of the terms and conditions of this Section 4. 
 (d) Consequences of
Non-Delivery. After the time at which the Offered Shares are required to be delivered to the Company for transfer to the Company pursuant to subsection (b) above, the Company shall not pay any
dividend to the Participant on account of such Offered Shares or permit the Participant to exercise any of the privileges or rights of a stockholder with respect to such Offered Shares, but shall, insofar as permitted by law, treat the Company as
the owner of such Offered Shares. 
 (e) Exempt Transactions. The following transactions shall be exempt from the provisions of this
Section 4: 
 (1) any transfer of Shares to or for the benefit of any spouse, child or grandchild of the Participant, or to a trust for
their benefit; 
 (2) any transfer pursuant to an effective registration statement filed by the Company under the Securities Act of 1933, as
amended (the “Securities Act”) or analogous laws of non-U.S. jurisdictions; and 
 (3) the
sale of all or substantially all of the outstanding shares of capital stock of the Company (including pursuant to a merger or consolidation); 

provided, however, that in the case of a transfer pursuant to clause (1) above, such Shares shall remain subject to the right of first
refusal set forth in this Section 4. 
 (f) Assignment of Company Right. The Company may assign its rights to purchase Offered
Shares in any particular transaction under this Section 4 to one or more persons or entities. 
 (g) Termination. The provisions
of this Section 4 shall terminate upon the earlier of the following events: 
 (1) the closing of the sale of Ordinary Shares in an
underwritten public offering pursuant to an effective registration statement filed by the Company under the Securities Act or analogous non-U.S. law; or 

(2) the sale of all or substantially all of the outstanding shares of capital stock, assets or business of the Company, by merger,
consolidation, sale of assets or otherwise (other than a merger or consolidation in which all or substantially all of the individuals and entities who were beneficial owners of the Company’s voting securities immediately prior to such
transaction beneficially own, directly or indirectly, more than 75% (determined on an as-converted basis) of the outstanding securities entitled to vote generally in the election of directors of the resulting,
surviving or acquiring corporation in such transaction). 

 (h) No Obligation to Recognize Invalid Transfer. The Company shall not be required
(1) to transfer on its books any of the Shares which shall have been sold or transferred in violation of any of the provisions set forth in this Section 4, or (2) to treat as owner of such Shares or to pay dividends to any transferee
to whom any such Shares shall have been so sold or transferred. 
 (i) Legends. The certificate representing Shares shall bear a
legend substantially in the following form (in addition to, or in combination with, any legend required by applicable federal and state securities laws and agreements relating to the transfer of the Company securities): 

“The shares represented by this certificate are subject to a right of first refusal in favor of the Company, as provided in a certain
stock option agreement with the Company.” 
  

	6.	 Agreement in Connection with Initial Public Offering. 

The Participant agrees, in connection with the initial underwritten public offering of the Ordinary Shares pursuant to a registration statement
under the Securities Act or analogous non-U.S. law, (i) not to (a) offer, pledge, announce the intention to sell, sell, contract to sell, sell any option or contract to purchase, purchase any option
or contract to sell, grant any option, right or warrant to purchase, or otherwise transfer or dispose of, directly or indirectly, any Ordinary Shares or any other securities of the Company or (b) enter into any swap or other agreement that
transfers, in whole or in part, any of the economic consequences of ownership of shares of Common Stock or other securities of the Company, whether any transaction described in clause (a) or (b) is to be settled by delivery of securities, in
cash or otherwise, during the period beginning on the date of the filing of such registration statement with the Securities and Exchange Commission and ending 180 days after the date of the final prospectus relating to the offering (plus up to an
additional 34 days to the extent requested by the managing underwriters for such offering in order to address Rule 2711(f) of the National Association of Securities Dealers, Inc. or any similar successor provision or any analogous non-U.S. governing or regulatory entity or authority), and (ii) to execute any agreement reflecting clause (i) above as may be requested by the Company or the managing underwriters at the time of such
offering. The Company may impose stop-transfer instructions with respect to the Ordinary Shares or other securities subject to the foregoing restriction until the end of the “lock-up” period. 

 

	7.	 Tax Matters. 

(a) Withholding. No Shares will be issued pursuant to the exercise of this option unless and until the Participant pays to the Company,
or makes provision satisfactory to the Company for payment of, any federal, state or local withholding taxes required by law to be withheld in respect of this option. 

(b) Liability for Taxes. The Participant has reviewed with the Participant’s own tax advisors the federal, state, local and foreign
tax consequences of the transactions contemplated by this option. The Participant is relying solely on such advisors and not on any statements or representations of the Company or any of its agents. The Participant understands that the Participant
(and not the Company) shall be responsible for the Participant’s tax liability that may arise as a result of the grant or exercise of this option, or the disposition of any Shares acquired on the exercise of this option. 

	8.	 Transfer Restrictions and Voting. 

(a) Transferability of Option. This option may not be sold, assigned, transferred, pledged or otherwise encumbered by the Participant,
either voluntarily or by operation of law, except by will or the laws of descent and distribution, and, during the lifetime of the Participant, this option shall be exercisable only by the Participant. 

(b) Transferability of Ordinary Shares. The Participant agrees that he or she will not transfer any Ordinary Shares issued pursuant to
the exercise of this option unless the transferee, as a condition to such transfer, delivers to the Company a written instrument confirming that such transferee shall be bound by all of the terms and conditions of Section 4 and Section 5;
provided that such a written confirmation shall not be required with respect to (1) Section 4 after such provision has terminated in accordance with Section 4(g) or (2) Section 5 after the completion of the lock-up period in connection with the Company’s initial underwritten public offering. 
 (c)
Voting. The Participant agrees that in relation to the Ordinary Shares received upon exercise of this option, the Participant shall exercise any voting rights attaching to such Ordinary Shares as directed by the Board of Directors of the
Company. 
  

	9.	 Provisions of the Plan. 

This option is subject to the provisions of the Plan (including the provisions relating to amendments to the Plan), a copy of which is
furnished to the Participant with this option. 
  

	10.	 Miscellaneous. 

(a) No Rights to Employment. The Participant acknowledges and agrees that the transactions contemplated hereunder and the vesting
schedule set forth herein do not constitute an express or implied promise of engagement as an employee or consultant for the vesting period, for any period, or at all. 

(b) Severability. The invalidity or unenforceability of any provision of this Agreement shall not affect the validity or enforceability
of any other provision of this Agreement, and each other provision of this Agreement shall be severable and enforceable to the extent permitted by law. 

(c) Waiver. Any provision for the benefit of the Company contained in this Agreement may be waived, either generally or in any
particular instance, by the Board of Directors of the Company. 
 (d) Binding Effect. This Agreement shall be binding upon and inure
to the benefit of the Company and the Participant and their respective heirs, executors, administrators, legal representatives, successors and assigns, subject to the restrictions on transfer set forth in Section 7 of this Agreement. 

(e) Notice. All notices required or permitted hereunder shall be in writing and deemed effectively given: (i) upon personal
delivery to the party to be notified, (ii) when sent by confirmed electronic email or facsimile if sent during normal business hours of the recipient, (iii) five (5) days after being sent by registered or certified mail, return receipt
requested, postage prepaid, or (iv) one 

 
(1) day after deposit with an internationally recognized overnight courier, specifying next day delivery, with written verification of receipt. All communications shall be sent to the respective
parties at the following addresses (or at such other addresses as shall be specified by notice given in accordance with this Section 9(e), if to the Participant, to the address set forth below or at the address shown on the records of the
Company, and if to the Company, at the address set forth below, attention Finance Director. 
 (f) Pronouns. Whenever the context may
require, any pronouns used in this Agreement shall include the corresponding masculine, feminine or neuter forms, and the singular form of nouns and pronouns shall include the plural, and vice versa. 

(g) Entire Agreement. This Agreement constitutes the entire agreement between the parties, and supersedes all prior agreements and
understandings relating to the subject matter of this Agreement. 
 (h) Amendment. This Agreement may be amended or modified only by a
written instrument executed by both the Company and the Participant. 
 (i) Governing Law. This Agreement shall be construed,
interpreted and enforced in accordance with the English law. 
 (j) Participant’s Acknowledgments. The Participant acknowledges
that he or she: (i) has been represented in the preparation, negotiation, and execution of this Agreement by legal counsel of the Participant’s own choice or has voluntarily declined to seek such counsel; (ii) understands the terms
and consequences of this Agreement; and (iii) is fully aware of the legal and binding effect of this Agreement. 

 IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of
the day and year first above written. 
  

					
	EXECUTED as a DEED by	 	)	  	
	ROCKLEY PHOTONICS LIMITED	 	)	  	  

	acting by:	 	)	  	Director
		 	)	  	
		 	)	  	  

		 	 )
	  	Director/Secretary
	 EXECUTED AND DELIVERED as a DEED ) By [             ]

	 		  	
	in the presence of:	 	)	  	  

		 	)	  	Participant
			
	Witness signature:	 		  	
			
	Witness name, address and occupation:	 		  	

 ROCKLEY PHOTONICS LIMITED 

Incentive Stock Option Agreement 

Granted Under 2013 Equity Incentive Plan 
  

	1.	 Grant of Option. 

This agreement evidences the grant by Rockley Photonics Limited, a company registered in England and Wales under No. 08683015 whose
registered office address is: c/o Cooley (UK) LLP, 10th Floor, Dashwood, 69 Old Broad Street, London, EC2M 1QS (the “Company”), on [.....................] (the “Grant Date”) to
[.....................] (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2013 Equity Incentive Plan (the “Plan”), a total of ordinary
shares, nominal value £0.00001 per share in the capital of the Company (the “Shares”), of the Company (“Ordinary Shares”) at $[.........] per Share. Unless earlier terminated, this option shall expire at 5:00 p.m.,
Eastern time, on [... + 10yrs, -1 day ......] (the “Final Exercise Date”). 
 It
is intended that the option evidenced by this agreement shall be an incentive stock option as defined in Section 422 of the United States Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the
“Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms. 

 

	2.	 Vesting Schedule. 

This option will become exercisable (“vest”) as to 25% of the original number of Shares on the first anniversary of the Vesting
Commencement Date (as defined below) and as to an additional 2.0833% of the original number of Shares at the end of each successive monthly period following the first anniversary of the Vesting Commencement Date until the fourth anniversary of the
Vesting Commencement Date. The Vesting Commencement Date shall be [....................]. 
 The right of exercise shall
be cumulative so that to the extent the option is not exercised in any period to the maximum extent permissible it shall continue to be exercisable, in whole or in part, with respect to all Shares for which it is vested until the earlier of the
Final Exercise Date or the termination of this option under Section 3 hereof or the Plan. 
  

	3.	 Exercise of Option. 

(a) Form of Exercise. Each election to exercise this option shall be in writing, signed by the Participant, and received by the Company
at its principal office, accompanied by this agreement, and payment in full in the manner provided in the Plan. The Participant may purchase less than the number of shares covered hereby, provided that no partial exercise of this option may be for
any fractional share. 
 (b) Continuous Relationship with the Company Required. Except as otherwise provided in this Section 3,
this option may not be exercised unless the Participant, at the time he or she exercises this option, is, and has been at all times since the Grant Date, an employee or officer of, or consultant or advisor to, the Company or any parent or subsidiary
of the Company as defined in Section 424(e) or (f) of the Code (an “Eligible Participant”). 

  
 1 

 (c) Termination of Relationship with the Company. If the Participant ceases to be an
Eligible Participant for any reason, then, except as provided in paragraphs (d) and (e) below, the right to exercise this option shall terminate three months after such cessation (but in no event after the Final Exercise Date), provided that
this option shall be exercisable only to the extent that the Participant was entitled to exercise this option on the date of such cessation. Notwithstanding the foregoing, if the Participant, prior to the Final Exercise Date, violates the non-competition or confidentiality provisions of any employment contract, confidentiality and nondisclosure agreement or other agreement between the Participant and the Company, the right to exercise this option
shall terminate immediately upon such violation. 
 (d) Exercise Period Upon Death or Disability. If the Participant dies or becomes
disabled (within the meaning of Section 22(e)(3) of the Code) prior to the Final Exercise Date while he or she is an Eligible Participant and the Company has not terminated such relationship for “cause” as specified in paragraph
(e) below, this option shall be exercisable, within the period of one year following the date of death or disability of the Participant, by the Participant (or in the case of death by an authorized transferee), provided that this option shall
be exercisable only to the extent that this option was exercisable by the Participant on the date of his or her death or disability, and further provided that this option shall not be exercisable after the Final Exercise Date. 

(e) Termination for Cause. If, prior to the Final Exercise Date, the Participant’s employment is terminated by the Company for
Cause (as defined below), the right to exercise this option shall terminate immediately upon the effective date of such termination of employment. If, prior to the Final Exercise Date, the Participant is given notice by the Company of the
termination of his or her employment by the Company for Cause, and the effective date of such employment termination is subsequent to the date of delivery of such notice, the right to exercise this option shall be suspended from the time of the
delivery of such notice until the earlier of (i) such time as it is determined or otherwise agreed that the Participant’s employment shall not be terminated for Cause as provided in such notice or (ii) the effective date of such
termination of employment (in which case the right to exercise this option shall, pursuant to the preceding sentence, terminate upon the effective date of such termination of employment). If the Participant is party to an employment or severance
agreement with the Company that contains a definition of “cause” for termination of employment, “Cause” shall have the meaning ascribed to such term in such agreement. Otherwise, “Cause” shall mean willful misconduct by
the Participant or willful failure by the Participant to perform his or her responsibilities to the Company (including, without limitation, breach by the Participant of any provision of any employment, consulting, advisory, nondisclosure, non-competition or other similar agreement between the Participant and the Company), as determined by the Company, which determination shall be conclusive. The Participant’s employment shall be considered to
have been terminated for Cause if the Company determines, within 30 days after the Participant’s resignation, that termination for Cause was warranted. 
  

	4.	 Company Right of First Refusal. 

(a) Notice of Proposed Transfer. If the Participant proposes to sell, assign, transfer, pledge, hypothecate or otherwise dispose of, by
operation of law or otherwise (collectively, “transfer”) any Ordinary Shares acquired upon exercise of this option, then the Participant shall first give written notice of the proposed transfer (the “Transfer Notice”) to the
Company. The Transfer Notice shall name the proposed transferee and state the number of such Ordinary Shares the Participant proposes to transfer (the “Offered Shares”), the price per share and all other material terms and conditions of
the transfer. 

  
 2 

 (b) Company Right to Purchase. For 30 days following its receipt of such Transfer
Notice, the Company shall have the option to purchase all or part of the Offered Shares at the price and upon the terms set forth in the Transfer Notice. In the event the Company elects to purchase all or part of the Offered Shares, it shall give
written notice of such election to the Participant within such 30-day period. Within 10 days after his or her receipt of such notice, the Participant shall tender to the Company at its principal offices the
certificate or certificates representing the Offered Shares to be purchased by the Company, duly endorsed in blank by the Participant or with duly endorsed stock powers attached thereto, all in a form suitable for transfer of the Offered Shares to
the Company. Promptly following receipt of such certificate or certificates, the Company shall deliver or mail to the Participant a check in payment of the purchase price for such Offered Shares; provided that if the terms of payment set forth in
the Transfer Notice were other than cash against delivery, the Company may pay for the Offered Shares on the same terms and conditions as were set forth in the Transfer Notice; and provided further that any delay in making such payment shall not
invalidate the Company’s exercise of its option to purchase the Offered Shares. 
 (c) Shares Not Purchased By Company. If the
Company does not elect to acquire all of the Offered Shares, the Participant may, within the 30-day period following the expiration of the option granted to the Company under subsection (b) above,
transfer the Offered Shares which the Company has not elected to acquire to the proposed transferee, provided that such transfer shall not be on terms and conditions more favorable to the transferee than those contained in the Transfer Notice.
Notwithstanding any of the above, all Offered Shares transferred pursuant to this Section 4 shall remain subject to the right of first refusal set forth in this Section 4 and such transferee shall, as a condition to such transfer, deliver
to the Company a written instrument confirming that such transferee shall be bound by all of the terms and conditions of this Section 4. 

(d) Consequences of Non-Delivery. After the time at which the Offered Shares are required to be
delivered to the Company for transfer to the Company pursuant to subsection (b) above, the Company shall not pay any dividend to the Participant on account of such Offered Shares or permit the Participant to exercise any of the privileges or
rights of a stockholder with respect to such Offered Shares, but shall, insofar as permitted by law, treat the Company as the owner of such Offered Shares. 

(e) Exempt Transactions. The following transactions shall be exempt from the provisions of this Section 4: 

(1) any transfer of Shares to or for the benefit of any spouse, child or grandchild of the Participant, or to a trust for their benefit; 

(2) any transfer pursuant to an effective registration statement filed by the Company under the Securities Act of 1933, as amended (the
“Securities Act”) or analogous laws of non-U.S. jurisdictions; and 

  
 3 

 (3) the sale of all or substantially all of the outstanding shares of capital stock of the
Company (including pursuant to a merger or consolidation); 
 provided, however, that in the case of a transfer pursuant to clause
(1) above, such Shares shall remain subject to the right of first refusal set forth in this Section 4. 
 (f) Assignment of
Company Right. The Company may assign its rights to purchase Offered Shares in any particular transaction under this Section 4 to one or more persons or entities. 

(g) Termination. The provisions of this Section 4 shall terminate upon the earlier of the following events: 

(1) the closing of the sale of Ordinary Shares in an underwritten public offering pursuant to an effective registration statement filed by the
Company under the Securities Act or analogous non-U.S. law; or 
 (2) the sale of all or
substantially all of the outstanding shares of capital stock, assets or business of the Company, by merger, consolidation, sale of assets or otherwise (other than a merger or consolidation in which all or substantially all of the individuals and
entities who were beneficial owners of the Company’s voting securities immediately prior to such transaction beneficially own, directly or indirectly, more than 75% (determined on an as-converted basis)
of the outstanding securities entitled to vote generally in the election of directors of the resulting, surviving or acquiring corporation in such transaction). 

(h) No Obligation to Recognize Invalid Transfer. The Company shall not be required (1) to transfer on its books any of the Shares
which shall have been sold or transferred in violation of any of the provisions set forth in this Section 4, or (2) to treat as owner of such Shares or to pay dividends to any transferee to whom any such Shares shall have been so sold or
transferred. 
 (i) Legends. The certificate representing Shares shall bear a legend substantially in the following
form (in addition to, or in combination with, any legend required by applicable federal and state securities laws and agreements relating to the transfer of the Company securities): 

“The shares represented by this certificate are subject to a right of first refusal in favor of the Company, as provided in a certain
stock option agreement with the Company.” 
  

	5.	 Agreement in Connection with Initial Public Offering. 

The Participant agrees, in connection with the initial underwritten public offering of the Ordinary Shares pursuant to a registration statement
under the Securities Act or analogous non-U.S. law, (i) not to (a) offer, pledge, announce the intention to sell, sell, contract to sell, sell any option or contract to purchase, purchase any option
or contract to sell, grant any option, right or warrant to purchase, or otherwise transfer or dispose of, directly or indirectly, any Ordinary Shares or any other securities of the Company or (b) enter into any swap or other agreement that
transfers, in whole or in part, any of the economic consequences of ownership of shares of Common Stock or other securities of the Company, whether any transaction described in clause (a) or (b) is to be settled by delivery of securities, in
cash or otherwise, during the period beginning on the date of the filing of such registration statement with the Securities and Exchange Commission and ending 180 

  
 4 

 
days after the date of the final prospectus relating to the offering (plus up to an additional 34 days to the extent requested by the managing underwriters for such offering in order to address
Rule 2711(f) of the National Association of Securities Dealers, Inc. or any similar successor provision or any analogous non-U.S. governing or regulatory entity or authority), and (ii) to execute any
agreement reflecting clause (i) above as may be requested by the Company or the managing underwriters at the time of such offering. The Company may impose stop-transfer instructions with respect to the Ordinary Shares or other securities
subject to the foregoing restriction until the end of the “lock-up” period. 
  

	6.	 Tax Matters. 

(a) Withholding. No Shares will be issued pursuant to the exercise of this option unless and until the Participant pays to the Company,
or makes provision satisfactory to the Company for payment of, any federal, state or local withholding taxes required by law to be withheld in respect of this option. 

(b) Disqualifying Disposition. If the Participant disposes of Shares acquired upon exercise of this option within two years from the
Grant Date or one year after such Shares were acquired pursuant to exercise of this option, the Participant shall notify the Company in writing of such disposition. 

(c) Liability for Taxes. The Participant has reviewed with the Participant’s own tax advisors the federal, state, local and foreign
tax consequences of the transactions contemplated by this option. The Participant is relying solely on such advisors and not on any statements or representations of the Company or any of its agents. The Participant understands that the Participant
(and not the Company) shall be responsible for the Participant’s tax liability that may arise as a result of the grant or exercise of this option, or the disposition of any Shares acquired on the exercise of this option. 

 

	7.	 Transfer Restrictions and Voting. 

(a) Transferability of Option. This option may not be sold, assigned, transferred, pledged or otherwise encumbered by the Participant,
either voluntarily or by operation of law, except by will or the laws of descent and distribution, and, during the lifetime of the Participant, this option shall be exercisable only by the Participant. 

(b) Transferability of Ordinary Shares. The Participant agrees that he or she will not transfer any Ordinary Shares issued pursuant to
the exercise of this option unless the transferee, as a condition to such transfer, delivers to the Company a written instrument confirming that such transferee shall be bound by all of the terms and conditions of Section 4 and Section 5;
provided that such a written confirmation shall not be required with respect to (1) Section 4 after such provision has terminated in accordance with Section 4(g) or (2) Section 5 after the completion of the lock-up period in connection with the Company’s initial underwritten public offering. 
 (c)
Voting. The Participant agrees that in relation to the Ordinary Shares received upon exercise of this option, the Participant shall exercise any voting rights attaching to such Ordinary Shares as directed by the Board of Directors of the
Company. 

  
 5 

	8.	 Provisions of the Plan. 

This option is subject to the provisions of the Plan (including the provisions relating to amendments to the Plan), a copy of which is
furnished to the Participant with this option. 
  

	9.	 Miscellaneous. 

(a) No Rights to Employment. The Participant acknowledges and agrees that the transactions contemplated hereunder and the vesting
schedule set forth herein do not constitute an express or implied promise of engagement as an employee or consultant for the vesting period, for any period, or at all. 

(b) Severability. The invalidity or unenforceability of any provision of this Agreement shall not affect the validity or enforceability
of any other provision of this Agreement, and each other provision of this Agreement shall be severable and enforceable to the extent permitted by law. 

(c) Waiver. Any provision for the benefit of the Company contained in this Agreement may be waived, either generally or in any
particular instance, by the Board of Directors of the Company. 
 (d) Binding Effect. This Agreement shall be binding upon and inure
to the benefit of the Company and the Participant and their respective heirs, executors, administrators, legal representatives, successors and assigns, subject to the restrictions on transfer set forth in Section 7 of this Agreement. 

(e) Notice. All notices required or permitted hereunder shall be in writing and deemed effectively given: (i) upon personal
delivery to the party to be notified, (ii) when sent by confirmed electronic email or facsimile if sent during normal business hours of the recipient, (iii) five (5) days after being sent by registered or certified mail, return receipt
requested, postage prepaid, or (iv) one (1) day after deposit with an internationally recognized overnight courier, specifying next day delivery, with written verification of receipt. All communications shall be sent to the respective parties
at the following addresses (or at such other addresses as shall be specified by notice given in accordance with this Section 9(e), if to the Participant, to the address set forth below or at the address shown on the records of the Company, and
if to the Company, at the address set forth below, attention Finance Director. 
 (f) Pronouns. Whenever the context may require, any
pronouns used in this Agreement shall include the corresponding masculine, feminine or neuter forms, and the singular form of nouns and pronouns shall include the plural, and vice versa. 

(g) Entire Agreement. This Agreement constitutes the entire agreement between the parties, and supersedes all prior agreements and
understandings relating to the subject matter of this Agreement. 
 (h) Amendment. This Agreement may be amended or modified only by a
written instrument executed by both the Company and the Participant. 
 (i) Governing Law. This Agreement shall be construed,
interpreted and enforced in accordance with the English law. 

  
 6 

 (j) Participant’s Acknowledgments. The Participant acknowledges that he or she:
(i) has been represented in the preparation, negotiation, and execution of this Agreement by legal counsel of the Participant’s own choice or has voluntarily declined to seek such counsel; (ii) understands the terms and consequences
of this Agreement; and (iii) is fully aware of the legal and binding effect of this Agreement. 

  
 7 

 IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the day and year
first above written. 
  

					
	 EXECUTED as a Deed by
 ROCKLEY
PHOTONICS LIMITED
 Acting by:
	  	 )
 )

)
 )

)
 )
	  	  
 Director

 
 Director/Secretary

	 EXECUTED AND DELIVERED as a DEED
 By
[             ]
 in the presence of:
	  	 )
 )

)
	  	  
 Participant

			
	 Witness signature:
  

Witness name, address and occupation:
	  		  	

  
 8EX-10.11

 Exhibit 10.11 

Execution Version 

INVESTMENT MANAGEMENT TRUST AGREEMENT 

This Investment Management Trust Agreement (this “Agreement”) is made effective as of July 11, 2019 by and
between SC Health Corporation, a Cayman Islands exempted company (the “Company”), and American Stock Transfer & Trust Company, LLC, a New York limited liability trust company (the “Trustee”).

 WHEREAS, the Company’s registration statement on Form S-1, File No. 333-232240 (the “Registration Statement”) and prospectus (the “Prospectus”) for the initial public offering of the Company’s units (the
“Units”), each of which consists of one of the Company’s Class A ordinary shares, par value $0.0001 per share (the “Ordinary Shares”), and one-half of
one warrant, each whole warrant entitling the holder thereof to purchase one Ordinary Share (such initial public offering hereinafter referred to as the “Offering”), has been declared effective as of the date hereof by the
U.S. Securities and Exchange Commission; and 
 WHEREAS, the Company has entered into an Underwriting Agreement (the
“Underwriting Agreement”) with Credit Suisse Securities (USA) LLC, as underwriter (the “Underwriter”); and 

WHEREAS, as described in the Prospectus, $150,000,000 of the gross proceeds of the Offering and sale of the Private Placement Warrants (as
defined in the Underwriting Agreement) (or $172,500,000 if the Underwriter’s over-allotment option is exercised in full) will be delivered to the Trustee to be deposited and held in a segregated, U.S. dollar-denominated trust account located in
the United States (the “Trust Account”) for the benefit of the Company and the holders of the Ordinary Shares included in the Units issued in the Offering as hereinafter provided (the amount to be delivered to the Trustee
(and any interest subsequently earned thereon) is referred to herein as the “Property,” the shareholders for whose benefit the Trustee shall hold the Property will be referred to as the “Public
Shareholders,” and the Public Shareholders and the Company will be referred to together as the “Beneficiaries”); and 

WHEREAS, pursuant to the Underwriting Agreement, a portion of the Property equal to $5,250,000 (or $6,037,500 if the Underwriter’s
over-allotment option is exercised in full) is attributable to deferred underwriting discounts and commissions that will be payable by the Company to the Underwriter upon and concurrently with the consummation of the Business Combination (as defined
below) (the “Deferred Discount”); and 
 WHEREAS, the Company and the Trustee desire to enter into this Agreement to
set forth the terms and conditions pursuant to which the Trustee shall hold the Property. 
 NOW THEREFORE, IT IS AGREED: 

1. Agreements and Covenants of Trustee. The Trustee hereby agrees and covenants to: 

(a) Hold the Property in trust for the Beneficiaries in accordance with the terms of this Agreement in the Trust Account established by the
Trustee in the United States at Deutsche Bank Trust Company Americas; 

 (b) Manage, supervise and administer the Trust Account subject to the terms and conditions
set forth herein; 
 (c) In a timely manner, upon the written instruction of the Company, invest and reinvest the Property in United States
government securities within the meaning of Section 2(a)(16) of the Investment Company Act of 1940, as amended, having a maturity of 180 days or less, or in money market funds meeting the conditions of paragraphs (d)(1), (d)(2), (d)(3) and
(d)(4) of Rule 2a-7 promulgated under the Investment Company Act of 1940, as amended (or any successor rule), which invest only in direct U.S. government treasury obligations, as determined by the Company; the
Trustee may not invest in any other securities or assets, it being understood that the Trust Account will earn no interest while account funds are uninvested awaiting the Company’s instructions hereunder; 

(d) Collect and receive, when due, all interest or other income arising from the Property, which shall become part of the
“Property,” as such term is used herein; 
 (e) Promptly notify the Company and the Underwriter of all communications received by
the Trustee with respect to any Property requiring action by the Company; 
 (f) Supply any necessary information or documents as may be
requested by the Company (or its authorized agents) in connection with the Company’s preparation of the tax returns relating to assets held in the Trust Account or in connection with the preparation or completion of the audit of the
Company’s financial statements by the Company’s auditors; 
 (g) Participate in any plan or proceeding for protecting or enforcing
any right or interest arising from the Property if, as and when instructed by the Company to do so; 
 (h) Render to the Company monthly
written statements of the activities of, and amounts in, the Trust Account reflecting all receipts and disbursements of the Trust Account; 

(i) Commence liquidation of the Trust Account only after and promptly after (x) receipt of, and only in accordance with, the terms of a
letter from the Company (the “Termination Letter”) in a form substantially similar to that attached hereto as either Exhibit A or Exhibit B, as applicable, signed on behalf of the Company by its Chief Executive
Officer, Chief Financial Officer or Chairman of the board of directors of the Company (the “Board”) or other authorized officer of the Company, and complete the liquidation of the Trust Account and distribute the Property in
the Trust Account, including interest earned on the funds held in the Trust Account (less up to $100,000 of interest to pay dissolution expenses and net of taxes payable), only as directed in the Termination Letter and the other documents referred
to therein, or (y) upon the date which is the later of (1) 18 months after the closing of the Offering and (2) such later date as may be approved by the Company’s shareholders in accordance with the Company’s amended and restated
memorandum and articles of association, if a Termination Letter has not been received by the Trustee prior to such date, in which case the Trust Account shall be liquidated in accordance with the procedures set forth in the Termination Letter
attached as Exhibit B and the Property in the Trust Account, including interest earned on the funds held in the Trust Account (less up to $100,000 of interest to pay dissolution expenses and net of taxes payable), shall be distributed to the
Public Shareholders of record as of such date; provided, however, that in the event the Trustee receives a Termination Letter in a form substantially similar to Exhibit B hereto, or if the Trustee begins to liquidate the Property because it
has received no such Termination Letter by the date specified in clause (y) of this Section 1(i), the Trustee shall keep the Trust Account open until twelve (12) months following the date the Property has
been distributed to the Public Shareholders; 

  
 -2- 

 (j) Upon written request from the Company, which may be given from time to time in a form
substantially similar to that attached hereto as Exhibit C, withdraw from the Trust Account and distribute to the Company the amount of interest earned on the Property requested by the Company to cover any tax obligation owed by the Company
as a result of assets of the Company or interest or other income earned on the Property, which amount shall be delivered directly to the Company by electronic funds transfer or other method of prompt payment, and the Company shall forward such
payment to the relevant taxing authority; provided, however, that to the extent there is not sufficient cash in the Trust Account to pay such tax obligation, the Trustee shall liquidate such assets held in the Trust Account as shall be
designated by the Company in writing to make such distribution so long as there is no reduction in the principal amount initially deposited in the Trust Account (it being acknowledged and agreed that any such amount in excess of interest income
earned on the Property shall not be payable from the Trust Account). The written request of the Company referenced above shall constitute presumptive evidence that the Company is entitled to said funds, and the Trustee shall have no responsibility
to look beyond said request; 
 (k) Upon written request from the Company, which may be given from time to time in a form substantially
similar to that attached hereto as Exhibit D, the Trustee shall distribute to the Company the amount requested by the Company to be used to redeem Ordinary Shares from Public Shareholders properly submitted in connection with a shareholder
vote to approve an amendment to the Company’s amended and restated memorandum and articles of association to modify the substance or timing of the Company’s obligation to redeem 100% of its public Ordinary Shares if the Company has not
consummated an initial Business Combination within the later of (1) 18 months after the closing of the Offering and (2) such later date as may be approved by the Company’s shareholders in accordance with the Company’s amended and
restated memorandum and articles of association. The written request of the Company referenced above shall constitute presumptive evidence that the Company is entitled to distribute said funds, and the Trustee shall have no responsibility to look
beyond said request; 
 (l) Only release the Property in accordance with a written instruction, signed by the Company’s Chairman of the
Board, Chief Executive Officer or Chief Financial Officer substantially in the form attached as Exhibit A, B, C or D, as applicable, attached hereto (each, a “Written Direction”); and 

(m) Not make any withdrawals or distributions from the Trust Account other than pursuant to Sections 1(i), (j) or
(k) above. 

  
 -3- 

 2. Agreements and Covenants of the Company. The Company hereby agrees and covenants
to: 
 (a) Give all instructions to the Trustee hereunder in writing, signed by the Company’s Chairman of the Board, Chief Executive
Officer or Chief Financial Officer. In addition, except with respect to its duties under Sections 1(i), (j) or (k) hereof, the Trustee shall be entitled to rely on, and shall be protected in relying on, any verbal or
telephonic advice or instruction which it, in good faith and with reasonable care, believes to be given by any one of the persons authorized above to give written instructions, provided that the Company shall promptly confirm such instructions in
writing; 
 (b) Subject to Section 4 hereof, hold the Trustee harmless and indemnify the Trustee from and against
any and all documented out-of-pocket expenses, including reasonable outside counsel fees and disbursements, or losses suffered by the Trustee in connection with any
action taken by it hereunder and in connection with any action, suit or other proceeding brought against the Trustee involving any claim, or in connection with any claim or demand, which in any way arises out of or relates to this Agreement, the
services of the Trustee hereunder, or the Property or any interest earned on the Property, except for expenses and losses resulting from the Trustee’s gross negligence, fraud or willful misconduct. Promptly after the receipt by the Trustee of
notice of demand or claim or the commencement of any action, suit or proceeding, pursuant to which the Trustee intends to seek indemnification under this Section 2(b), it shall notify the Company in writing of such claim
(hereinafter referred to as the “Indemnified Claim”). The Trustee shall have the right to conduct and manage the defense against such Indemnified Claim; provided that the Trustee shall obtain the consent of the Company
with respect to the selection of counsel, which consent shall not be unreasonably withheld. The Trustee may not agree to settle any Indemnified Claim without the prior written consent of the Company, which such consent shall not be unreasonably
withheld. The Company may participate in such action with its own counsel; 
 (c) Pay the Trustee the fees set forth on Schedule A
hereto, including an initial acceptance fee, annual administration fee, and transaction processing fee, which fees shall be subject to modification by the parties from time to time. It is expressly understood that the Property shall not be used to
pay such fees unless and until it is distributed to the Company pursuant to Sections 1(i) through 1(k) hereof. The Company shall pay the Trustee the initial acceptance fee and the first annual administration fee at the consummation of
the Offering. The Trustee shall refund to the Company the annual administration fee (on a pro rata basis) with respect to any period after the liquidation of the Trust Account. The Company shall not be responsible for any other fees or charges of
the Trustee except as set forth in this Section 2(c) and as may be provided in Section 2(b) hereof; 

(d) In connection with any vote of the Company’s shareholders regarding a merger, share exchange, asset acquisition, share purchase,
reorganization or similar business combination involving the Company and one or more businesses (the “Business Combination”), provide to the Trustee an affidavit or certificate of the inspector of elections for the
shareholder meeting verifying the vote of such shareholders regarding such Business Combination; 
 (e) Provide the Underwriter with a copy
of any Termination Letter(s) and/or any other correspondence that is sent to the Trustee with respect to any proposed withdrawal from the Trust Account promptly after it issues the same; 

  
 -4- 

 (f) Unless otherwise agreed between the Company and the Underwriter, ensure that any
Instruction Letter (as defined in Exhibit A) delivered in connection with a Termination Letter in the form of Exhibit A expressly provides that the Deferred Discount is paid directly to the account or accounts directed by the Underwriter
prior to any transfer of the funds held in the Trust Account to the Company or any other person; and 
 (g) Instruct the Trustee to make
only those distributions that are permitted under this Agreement, and refrain from instructing the Trustee to make any distributions that are not permitted under this Agreement. 

3. Limitations of Liability. The Trustee shall have no responsibility or liability to: 

(a) Imply obligations, perform duties, inquire or otherwise be subject to the provisions of any agreement or document other than this Agreement
and that which is expressly set forth herein; 
 (b) Take any action with respect to the Property, other than as directed in
Section 1 hereof, and the Trustee shall have no liability to any third party except for liability arising out of the Trustee’s gross negligence, fraud or willful misconduct; 

(c) Institute any proceeding for the collection of any principal and income arising from, or institute, appear in or defend any proceeding of
any kind with respect to, any of the Property unless and until it shall have received instructions from the Company given as provided herein to do so and the Company shall have advanced or guaranteed to it funds sufficient to pay any expenses
incident thereto; 
 (d) Refund any depreciation in principal of any Property; 

(e) Assume that the authority of any person designated by the Company to give instructions hereunder shall not be continuing unless provided
otherwise in such designation, or unless the Company shall have delivered a written revocation of such authority to the Trustee; 
 (f) The
other parties hereto or to anyone else for any action taken or omitted by it, or any action suffered by it to be taken or omitted, in good faith and in the Trustee’s best judgment, except for the Trustee’s gross negligence, fraud or
willful misconduct. The Trustee may rely conclusively and shall be protected in acting upon any order, notice, demand, certificate, opinion or advice of counsel (including counsel chosen by the Trustee, which counsel may be the Company’s
counsel), statement, instrument, report or other paper or document (not only as to its due execution and the validity and effectiveness of its provisions, but also as to the truth and acceptability of any information therein contained) which the
Trustee believes, in good faith and with reasonable care, to be genuine and to be signed or presented by the proper person or persons. The Trustee shall not be bound by any notice or demand, or any waiver, modification, termination or rescission of
this Agreement or any of the terms hereof, unless evidenced by a written instrument delivered to the Trustee, signed by the proper party or parties and, if the duties or rights of the Trustee are affected, unless it shall give its prior written
consent thereto; 
 (g) Verify the accuracy of the information contained in the Registration Statement; 

  
 -5- 

 (h) Provide any assurance that any Business Combination entered into by the Company or any
other action taken by the Company is as contemplated by the Registration Statement; 
 (i) File information returns with respect to the
Trust Account with any local, state or federal taxing authority or provide periodic written statements to the Company documenting the taxes payable by the Company, if any, relating to any interest income earned on the Property; 

(j) Prepare, execute and file tax reports, income or other tax returns and pay any taxes with respect to any income generated by, and
activities relating to, the Trust Account, regardless of whether such tax is payable by the Trust Account or the Company, including, but not limited to, income tax obligations, except pursuant to Section 1(j) hereof; or

 (k) Verify calculations, qualify or otherwise approve the Company’s written requests for distributions pursuant to Sections
1(i), 1(j) or 1(k) hereof. 
 4. Trust Account Waiver. The Trustee has no right of
set-off or any right, title, interest or claim of any kind (“Claim”) to, or to any monies in, the Trust Account, and hereby irrevocably waives any Claim to, or to any monies in, the
Trust Account that it may have now or in the future. In the event the Trustee has any Claim against the Company under this Agreement, including, without limitation, under Section 2(b) or
Section 2(c) hereof, the Trustee shall pursue such Claim solely against the Company and its assets outside the Trust Account and not against the Property or any monies in the Trust Account. 

5. Termination. This Agreement shall terminate as follows: 

(a) If the Trustee gives written notice to the Company that it desires to resign under this Agreement, the Company shall use its reasonable
efforts to locate a successor trustee, pending which the Trustee shall continue to act in accordance with this Agreement. At such time that the Company notifies the Trustee that a successor trustee has been appointed and has agreed to become subject
to the terms of this Agreement, the Trustee shall transfer the management of the Trust Account to the successor trustee, including but not limited to the transfer of copies of the reports and statements relating to the Trust Account, whereupon this
Agreement shall terminate; provided, however, that in the event that the Company does not locate a successor trustee within ninety (90) days of receipt of the resignation notice from the Trustee, the Trustee may submit an
application to have the Property deposited with any court in the State of New York or with the United States District Court for the Southern District of New York and upon such deposit, the Trustee shall be immune from any liability whatsoever; or

 (b) At such time that the Trustee has completed the liquidation of the Trust Account and its obligations in accordance with the
provisions of Section 1(i) hereof (which section may not be amended under any circumstances) and distributed the Property in accordance with the provisions of the Termination Letter, this Agreement shall terminate except
with respect to Section 2(b). 

  
 -6- 

 6. Miscellaneous. 

(a) The Company and the Trustee each acknowledge that the Trustee will follow the security procedures set forth below with respect to funds
transferred from the Trust Account. The Company and the Trustee will each restrict access to confidential information relating to such security procedures to authorized persons. Each party must notify the other party immediately if it has reason to
believe unauthorized persons may have obtained access to such confidential information, or of any change in its authorized personnel. In executing funds transfers, the Trustee shall rely upon all information supplied to it by the Company, including,
account names, account numbers, and all other identifying information relating to a Beneficiary, Beneficiary’s bank or intermediary bank. Except for any liability arising out of the Trustee’s gross negligence, fraud or willful misconduct,
the Trustee shall not be liable for any loss, liability or out-of-pocket expense resulting from any error in the information or transmission of the funds. 

(b) This Agreement shall be governed by and construed and enforced in accordance with the laws of the State of New York, without giving effect
to conflicts of law principles that would result in the application of the substantive laws of another jurisdiction. This Agreement may be executed in several original or facsimile counterparts, each one of which shall constitute an original, and
together shall constitute but one instrument. 
 (c) This Agreement contains the entire agreement and understanding of the parties hereto
with respect to the subject matter hereof. Except for Section 1(i), 1(j) and 1(k) hereof (which sections may not be modified, amended or deleted without the affirmative vote of sixty-five percent (65%) of the
then outstanding Ordinary Shares and Class B ordinary shares, par value $0.0001 per share, of the Company, voting together as a single class; provided that no such amendment will affect any Public Shareholder who has properly elected to redeem
his, her or its Ordinary Shares in connection with a shareholder vote to amend this Agreement), this Agreement or any provision hereof may only be changed, amended or modified (other than to correct a typographical error) by a writing signed by each
of the parties hereto. 
 (d) The parties hereto consent to the jurisdiction and venue of any state or federal court located in the City of
New York, State of New York, for purposes of resolving any disputes hereunder. AS TO ANY CLAIM, CROSS-CLAIM OR COUNTERCLAIM IN ANY WAY RELATING TO THIS AGREEMENT, EACH PARTY WAIVES THE RIGHT TO TRIAL BY JURY. 

(e) Any notice, consent or request to be given in connection with any of the terms or provisions of this Agreement shall be in writing and
shall be sent by express mail or similar private courier service, by certified mail (return receipt requested), by hand delivery or by electronic mail: 

if to the Trustee, to: 
 American
Stock Transfer & Trust Company, LLC 
 6201 15th Avenue 

Brooklyn, New York 11219 
 Attn:
Felix Orihuela 
 Tel: (718) 921-8209 

Email: FOrihuela@astfinancial.com / 

treasurymanagement@astfinancial.com 

  
 -7- 

 if to the Company, to: 

SC Health Corporation 
 Attn:
Angelo John Coloma 
 Address: 108 Robinson Road #10-00 

Singapore 068900 
 Tel: +65 6438
1080 
 Email: aj.coloma@sincapital.com 

in each case, with copies to: 

Ropes & Gray LLP 
 1211
Avenue of the Americas 
 New York, New York 10036 

Attn: Paul Tropp 
 Email:
paul.tropp@ropesgray.com 
 and 

Credit Suisse Securities (USA) LLC 

Eleven Madison Avenue 
 New
York, New York 10010 
 Attn.: IBCM-Legal 

Fax No.: (212) 325-4296 

and 
 Shearman &
Sterling LLP 
 599 Lexington Avenue 

New York, New York 10022 

Attn.: Harald Halbhuber 
 Email:
harald.halbhuber@shearman.com 
 (f) Each of the Company and the Trustee hereby represents that it has the full right and power and
has been duly authorized to enter into this Agreement and to perform its respective obligations as contemplated hereunder. The Trustee acknowledges and agrees that it shall not make any claims or proceed against the Trust Account, including by way
of set-off, and shall not be entitled to any funds in the Trust Account under any circumstance. 

(g) This Agreement may not be assigned by the Trustee without the prior written consent of the Company. 

  
 -8- 

 (h) This Agreement is the joint product of the Trustee and the Company and each provision
hereof has been subject to the mutual consultation, negotiation and agreement of such parties and shall not be construed for or against any party hereto. 

(i) This Agreement may be executed in any number of counterparts, each of which shall be deemed to be an original, but all such counterparts
shall together constitute one and the same instrument. Delivery of a signed counterpart of this Agreement by facsimile or electronic transmission shall constitute valid and sufficient delivery thereof. 

(j) Each of the Company and the Trustee hereby acknowledges and agrees that the Underwriter is a third-party beneficiary of this Agreement.

 (k) Except as specified herein, no party to this Agreement may assign its rights or delegate its obligations hereunder to any other
person or entity. 
 [Signature Page Follows] 

  
 -9- 

 IN WITNESS WHEREOF, the parties have duly executed this Investment Management Trust
Agreement as of the date first written above. 
  

			
	AMERICAN STOCK TRANSFER & TRUST COMPANY, LLC, as Trustee
		
	By:	 	/s/ Michael A. Nespoli

 
			
	Name:	 	Michael A. Nespoli
	Title:	 	Executive Director

  

			
	SC HEALTH CORPORATION

 
			
		
	By:	 	/s/ David Sin

 
			
	Name:	 	David Sin
	Title:	 	Director

 [Signature Page to Investment Management Trust Agreement] 

 SCHEDULE A 
  

									
	 Fee Item
	  	 Time and method of payment
	  	Amount
	 Initial set-up fee.
	  	Initial closing of Offering by wire
transfer. Deferred until Business
Combination closing	  	$	 	 	  	$3,500
	 Trustee administration fee
	  	Payable annually. First year fee
payable, at initial closing of Offering
by wire transfer, thereafter by wire
transfer or check.	  	$	 	 	  	$5,500
	 Transaction processing fee for
disbursements to Company under
Section 1
	  	Deduction by Trustee from
accumulated income
following disbursement made to Company under
Section 1	  	$	 	 	  	$8,500
	 Paying Agent services as required
pursuant to Section 1(i)
	  	Billed to Company upon delivery of
service pursuant to Section 1(i)	  				  	Prevailing
rates

  
 A-1 

 EXHIBIT A 

[Letterhead of Company] 

[Insert date] 
 American Stock
Transfer & Trust Company, LLC 
 6201 15th Avenue 

Brooklyn, New York 11219 
 Attn: [•] 

 

	 	Re:	 Trust Account No. Termination Letter 

Ladies and Gentlemen: 
 Pursuant to
Section 1(i) of the Investment Management Trust Agreement between SC Health Corporation (the “Company”) and American Stock Transfer & Trust Company, LLC (the
“Trustee”), dated as of __________, 2019 (the “Trust Agreement”), this is to advise you that the Company has entered into an agreement with ___________ (the “Target Business”)
to consummate a business combination with Target Business (the “Business Combination”) on or about [insert date]. The Company shall notify you at least forty-eight (48) hours in advance of the actual date (or such
shorter time period as you may agree) of the consummation of the Business Combination (the “Consummation Date”). Capitalized terms used but not defined herein shall have the meanings set forth in the Trust
Agreement. 
 In accordance with the terms of the Trust Agreement, we hereby authorize you to commence to liquidate all of the assets of the
Trust Account on [insert date], and to transfer the proceeds into the trust checking account at Deutsche Bank Trust Company Americas to the effect that, on the Consummation Date, all of the funds held in the Trust Account will be
immediately available for transfer to the account or accounts that the Company shall direct on the Consummation Date (including as directed to it by the Underwriter (with respect to the Deferred Discount)). It is acknowledged and agreed that while
the funds are on deposit in said trust checking account awaiting distribution, neither the Underwriter nor the Company will earn any interest or dividends. 

On the Consummation Date (i) counsel for the Company shall deliver to you written notification that the Business Combination has been
consummated, or will be consummated concurrently with your transfer of funds to the accounts as directed by the Company (the “Notification”) and (ii) the Company shall deliver to you (a) a certificate of the Chief
Executive Officer of the Company, which verifies that the Business Combination has been approved by a vote of the Company’s shareholders, if a vote is held and (b) joint written instruction signed by the Company and the Underwriter with
respect to the transfer of the funds held in the Trust Account, including payment of amounts owed to public shareholders who have properly exercised their redemption rights and payment of the Deferred Discount directly to the account or accounts
directed by the Underwriter from the Trust Account (the “Instruction Letter”). You are hereby directed and authorized to transfer the funds held in the Trust Account immediately upon your receipt of the Notification and the
Instruction Letter, in accordance with the terms of the Instruction Letter. In the event that certain deposits held in the Trust Account may not be liquidated by the Consummation Date without penalty, you will notify the Company in writing of the
same and the Company shall direct you as to whether such funds should remain in the Trust Account and be distributed after the Consummation Date to the Company. Upon the distribution of all the funds, net of any payments necessary for reasonable
unreimbursed expenses related to liquidating the Trust Account, your obligations under the Trust Agreement shall be terminated. 

  
 A-2 

 In the event that the Business Combination is not consummated on the Consummation Date
described in the notice thereof and we have not notified you on or before the original Consummation Date of a new Consummation Date, then upon receipt by the Trustee of written instructions from the Company, the funds held in the Trust Account shall
be reinvested as provided in Section 1(c) of the Trust Agreement on the business day immediately following the Consummation Date as set forth in such notice as soon thereafter as possible. 

 

			
	Very truly yours,
	
	SC HEALTH CORPORATION

 
			
		
	By:	 	 

 
			
	Name:	 	
	Title:	 	

 cc: Credit Suisse Securities (USA) LLC 

  
 A-3 

 EXHIBIT B 

[Letterhead of Company] 

[Insert date] 
 American Stock
Transfer & Trust Company, LLC 
 6201 15th Avenue 

Brooklyn, New York 11219 
 Attn: [•] 

 

	 	Re:	 Trust Account No. Termination Letter 

Ladies and Gentlemen: 
 Pursuant to
Section 1(i) of the Investment Management Trust Agreement between SC Health Corporation (the “Company”) and American Stock Transfer & Trust Company, LLC (the
“Trustee”), dated as of __________, 2019 (the “Trust Agreement”), this is to advise you that the Company has been unable to effect a business combination with a Target Business (the
“Business Combination”) within the time frame specified in the Company’s Amended and Restated Memorandum and Articles of Association, as described in the Company’s Prospectus relating to the Offering. Capitalized
terms used but not defined herein shall have the meanings set forth in the Trust Agreement. 
 In accordance with the terms of the Trust
Agreement, we hereby authorize you to liquidate all of the assets in the Trust Account on ____________, 20___ and to transfer the total proceeds into the trust checking account at Deutsche Bank Trust Company Americas to await distribution to the
Public Shareholders. The Company has selected __________ as the record date for the purpose of determining the Public Shareholders entitled to receive their share of the liquidation proceeds. [You agree to be the Paying Agent of record and, in your
separate capacity as Paying Agent, agree to distribute said funds directly to the Company’s Public Shareholders in accordance with the terms of the Trust Agreement and the Amended and Restated Memorandum and Articles of Association of the
Company.] Upon the distribution of all the funds, your obligations under the Trust Agreement shall be terminated, except to the extent otherwise provided in Section 1(i) of the Trust Agreement. 

 

			
	Very truly yours,
	
	SC HEALTH CORPORATION

 
			
		
	By:	 	 

 
			
	Name:	 	
	Title:	 	

 cc: Credit Suisse Securities (USA) LLC 

  
 B-1 

 EXHIBIT C 

[Letterhead of Company] 

[Insert date] 
 American Stock
Transfer & Trust Company, LLC 
 6201 15th Avenue 

Brooklyn, New York 11219 
 Attn: [•] 

 

	 	Re:	 Trust Account No. Tax Payment - Withdrawal Instruction  

Ladies and Gentlemen: 
 Pursuant to
Section 1(j) of the Investment Management Trust Agreement between SC Health Corporation (the “Company”) and American Stock Transfer & Trust Company (the “Trustee”),
dated as of __________, 2019 (the “Trust Agreement”), the Company hereby requests that you deliver to the Company $___________ of the interest income earned on the Property as of the date hereof. Capitalized terms used but
not defined herein shall have the meanings set forth in the Trust Agreement. 
 The Company needs such funds to pay for the tax obligations
as set forth on the attached tax return or tax statement. In accordance with the terms of the Trust Agreement, you are hereby directed and authorized to transfer (via wire transfer) such funds promptly upon your receipt of this letter to the
Company’s operating account at: 
 [WIRE INSTRUCTION INFORMATION] 

 

			
	Very truly yours,
	
	SC HEALTH CORPORATION

 
			
		
	By:	 	 

 
			
	Name:	 	
	Title:	 	

 cc: Credit Suisse Securities (USA) LLC 

  
 C-1 

 EXHIBIT D 

[Letterhead of Company] 

[Insert date] 
 American Stock
Transfer & Trust Company, LLC 
 6201 15th Avenue 

Brooklyn, New York 11219 
 Attn: [•] 

 

	 	Re:	 Trust Account No. Shareholder Redemption Withdrawal Instruction 

Ladies and Gentlemen: 
 Pursuant to
Section 1(k) of the Investment Management Trust Agreement between SC Health Corporation (the “Company”) and American Stock Transfer & Trust Company, LLC (the
“Trustee”), dated as of __________, 2019 (the “Trust Agreement”), the Company hereby requests that you withdraw $___________ of the principal and interest income earned on the Property as of the date
hereof. Capitalized terms used but not defined herein shall have the meanings set forth in the Trust Agreement. 
 The Company needs such
funds to pay the Company’s public shareholders who have properly elected to have their Ordinary Shares redeemed by the Company in connection with a shareholder vote to approve an amendment to the Company’s amended and restated memorandum
and articles of association to modify the substance or timing of the Company’s obligation to redeem 100% of its public Ordinary Shares if the Company has not consummated an initial Business Combination within 18 months from the closing of the
Offering. As such, you are hereby directed and authorized to transfer (via wire transfer) such funds promptly upon your receipt of this letter to the redeeming Public Shareholders in accordance with your customary procedures. 

 

			
	Very truly yours,
	
	SC HEALTH CORPORATION

 
			
		
	By:	 	 

 
			
	Name:	 	
	Title:	 	

 cc: Credit Suisse Securities (USA) LLC 

  
 D-1

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00325-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00325-of-00352.parquet"}]]